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SUMMARY
Weight loss is a common complaint amongst patients with chronic 
obstructive lung disease (COPD). Irrespective of the severity of airflow 
obstruction, COPD patients who lose weight suffer a greater mortality 
and morbidity than their weight stable peers. Whilst the poor prognostic 
implication of weight loss is well recognised, the exact cause for its 
occurrence in these patients is unknown.
The main aim of the investigations that comprise this thesis was 
to study the contributions of the energy cost of breathing, beta agonist 
therapy and acute infective exacerbations to the energy balance of 
patients suffering from chronic respiratory disease. A subsidiary aim was 
to study methods of improving the nutritional status of malnourished 
patients with COPD.
In all the studies resting energy expenditure (REE) was measured 
by indnect calorimetry using a non-invasive ventilated hood system for 
expired gas collection. The hood system was used following a study of 
patients with severe respiratory impairment which revealed that the more 
widely used mouth-piece system, probably due to its invasive nature, 
resulted in an over estimation of REE.
Patient with deformities of the chest wall due to scoliosis and 
thoracoplasty ai’e known to suffer from a mechanical inefficiency of the 
thoracic cage which results in an increased work of breathing. In order to
detect whether increased work of breatliing always results in an elevation
-■;ï.
of REE, REE was estimated in twenty patients with chest wall disease
-4:
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and ten controls. This study showed that despite a major impairment of 
lung function, and by implication an increase in the work of breathing, 
REE was not elevated in patients with chest wall disease.
The next study involved tlie measurement of the oxygen cost of 
breathing in patients with respiratory impairment due to chest wall 
disease and COPD. The oxygen cost of breathing was estimated by a 
previously described method involving the addition of a dead space to 
tlie breathing circuit. REE, oxygen cost of breathing and nutiitional 
status were measured in six patients with scoliosis, six patients with 
thoracoplasty, six patients with COPD and six controls. It was found that 
whilst tlie oxygen cost of breathing was inversely related to lung 
function, there was no relation between oxygen cost of breathing and
REE or nutiitional status. It was concluded that the oxygen cost of 
breathing could not be the sole or major cause of weight loss in COPD 
patients.
Beta adienergic drugs, including salbutamol, are known to cause a 
dose dependent increase in energy expenditure. The thennogenic and 
heart rate response to an 800 j-lgm inhaled dose of salbutamol was 
measured in twelve COPD patients and twelve controls. The 
thermogenic and heart rate response to salbutamol was blunted in 
patients compared with controls, leading to the conclusion that the 
thennogenic effect of beta agonist drug therapy does not result in a state 
of negative energy balance in patients with chronic lung disease.
The effect of an acute exacerbation of disease on the energy 
balance of COPD patients was the focus of a further study. REE and
16 %
patients;
calorific intake were estimated in twenty patients hospitalised with an 
acute infective exacerbation of COPD. All patients exhibited an increase 
in REE at the time of admission and even at the time of discharge they 
were in a state of considerable energy deficit.
Two studies were conducted to assess the efficacy of nutritional 
programmes for malnourished COPD patients. The first study, employing 
a standard outpatient approach of dietaiy advice and supplement 
provision, did not improve the nutritional status or respiratory function . 
A second study involving the use of Clenbuterol, a beta agonist with 
muscle performance enhancing properties, showed that nutritional 
supplementation plus Clenbuterol in a conventional dose of 20 |i  gms 
twice daily, did not improve nutritional status, respkatory muscle 
stiength or lung function.
In conclusion, the studies comprising this thesis have shown
that:
(1) In patients with severe respiratory impairment resting energy 
expenditure is better measured by a hood than a mouth piece system of 
indirect calorimetiy;
(2) The oxygen cost of breathing is not in itself an important cause of 
poor nutiitional status in patients with lung disease;
(3) The thermogenic effect of beta agonist drugs is blunted in patients
I
■I
with COPD who are long term users of the drag; beta agonist therapy is 
unlikely to be an important cause of negative energy balance in these
17
(4) Patients with COPD suffer a state of considerable negative energy 
balance during an acute infective exacerbation which could contribute to 
cachexia in COPD;
(5) Outpatient based nutritional supplementation programmes on their 
own or in conjunction with Clenbuterol at a dose of 20 p, gms twice daily 
do not improve nutritional status or lung function in malnourished 
patients with COPD.
:s
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PROLOGUE
Factors related to nutrition are being increasingly 
implicated in tlie pathogenesis of a wide variety of diseases. Most 
attention has focused on the now well established link between diet, 
energy imbalance (obesity) and cardiovascular disease, particulaidy 
coronary aitery disease (WHO Expert Committee, 1982). The critical 
role of nuti'ition has also been recognised with regard to chronic disease 
states of the other organ systems, for e.g., the primacy of dietary 
measures in the management of metabolic disorders like diabetes (Lean 
et al, 1991); the relation between poor nutritional status and failure of 
the immune system (Chandra, 1990); the value of nutritional support and 
dietary modification in renal and liver failure (Lee, 1980); and the 
importance of special diets in the management of disorders of the 
gastrointestinal system (Cummings, 1993). The part played by nutrition 
in the pathogenesis of cancer has also been the subject of extensive 
research in recent years (Doll and Peto, 1981).
i |  
i
In striking contrast to the situation pertaining to the other
organ systems, tlie relation between nutrition and diseases of the j'j
respiratory system has received little attention. Major texts of nutrition
often mention tlie lungs only in passing, or not at all (James and GaiTow, 
1993). Some of the reasons for this relative neglect can, however, be 
postulated. Firstly, asthma excluded, the most common respiratory
diseases of the present day, chronic obstructive lung disease and lung
cancer, are principally caused by smoking (Doll and Peto, 1976). The
19
link between cigarette smoking and these diseases is so strong and 
obvious that other factors like nutiition have been subjected to less 
scrutiny than would otherwise have been the case. Secondly, even in 
those respiratory diseases like cystic fibrosis and emphysema, where 
nutrition plays a significant role, the relationship between nutrition and 
disease state is not directly causal, depending on modification of immune 
and metabolic mechanisms, rendering assessment of the role of nutrition 
in the pathological process difficult.
As will become apparent as this thesis unfolds, the link 
between nutiition, energy balance and resphatory function is well worth 
studying, not only for the obvious clinical implications it has in the 
management of patients witli respiratory dysfunction, but also for the 
interesting insights it provides into the complex relation between our 
breathing and bodily habitus.
Ï
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In view of the common use of abbreviations, in particulai' in the fields of 
calorimetry and respiratory function testing, this brief introduction 
defines some of tlie key abbreviations and terms used in this thesis.
R E E  - Resting energy expenditure; in practice, the minimum energy 
expenditure of an awake individual in a restful supine or semi-supine
Definitions and abbreviations
posture after an overnight fast.
V O 2  - Oxygen consumption; expressed usually in ml /  min.
V C O 2  - Carbon dioxide production; expressed in ml /  min.
RER - Respiratory exchange ratio; ratio between carbon dioxide 
production and oxygen consumption; usually refers to expired gas; does 
not assume steady state.
RQ  - Respiratory Quotient; ratio between carbon dioxide production and
oxygen consumption; usually refers to tissues; assumes steady state.
FEY I  - Forced expired volume in 1 second; defined as the maximal
■ ■■
volume of gas that can be expired from the lungs in the first second of a 
forced expiration from a position of full inspiration.
VC Vital capacity; in this study refers to forced vital capacity which is 
defined as the maximal volume of gas that can be expired from the lungs 
during a forced expiration from a position of full inspiration.
BM I - Body mass index or the Quetlet Index; weight in kilograms 
divided by (height in metres) [ W t in kg /  {ht} ^].
.-.■i
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% IBW  " Percentage of ideal body weight as predicted from the 
Metropolitan Life Assurance Co., tables.
TSF - Triceps skinfold thickness 
M AC - Mid upper arm ckcumference.
M A M C - Mid arm muscle circumference.
22
CHAPTER 1: Literature review and background
Wliile clinical interest in the relation between nutrition and 
respiratory dysfunction in patients witli emphysema and cystic fibrosis is 
a recent phenomenon, remarkably comprehensive information on the 
effects of malnutrition on ventilatoiy function has been available since the 
early paid of this centuiy. This chapter seeks to provide a historical 
backgi'ound to the investigations in the field of nutrition and lung disease 
and summarises the current state of knowledge in this ai*ea, setting the 
scene for the vaiious studies that form the basis of this thesis.
1.1 Effects of starvation on lung structure and function - 
results of the Carnegie, Minnesota and Warsaw camp 
studies
In 1919 Benedict and others published the results of their 
starvation experiments on human volunteers (Benedict et al, 1919). 
Thirty- four subjects from the Young Men's Christian Association 
College in Springfield, Mass. were placed on a diet which provided about 
60% of recommended energy requirements for a period of three months. 
Valions physiologic changes which accompanied the weight loss (about 
10% of initial body weight) on this diet were measured. It was noted that 
after weight loss the overall basal heat production or, as it is now known, 
resting energy expenditure (REE), fell by 20% and oxygen consumption 
by 18%. Minute ventilation was recorded to have fallen from an average 
of 5.09 liti'es per minute to 4.49 litres per minute, although there was no
23
accompanying change in the alveolar carbon dioxide tensions. The 
essentially negative effect of nutritional deprivation on ventilatory 
function was confinned by the Minnesota experiments (Keys et al, 1950). 
The mean weight loss achieved in this study after a starvation period of 
24 weeks was 24% of initial body weight. This was accompanied by a 
fall in basal metabolic rate of 25 - 40%. Vital capacity fell by an average 
of 390 miUiliti'es while minute ventilation fell from an average of 4.82 
litres to 3.35 liti'es. M ost interestingly, respiratoiy efficiency, which was 
arbitrarily defined as the amount of oxygen removed (in millilitres) per 
litre of expired air, decreased by 16% during aerobic work and 11% 
during anaerobic work. While the vital capacity returned to baseline 
values after 12 weeks of refeeding, measures of respiratory efficiency 
took a longer time (20 weeks) to return to noimal. Although no measure 
of respiratory muscle strength was made, the conclusion was that the 
deleterious effect of starvation on ventilation resulted from weakness of 
the respiiatory muscles.
While the Carnegie experiments and the Minnesota studies 
provide useful infonnation on the effect of nutritional depletion on 
ventilatoiy function, the most striking observations on the effect of
I
Starvation on respii atory morbidity come from the studies of the Jewish
physicians in the Warsaw ghettos in the eaiJy 1940s (Winick, 1979). 
Under the leadership of Dr. Israel Milejowski a group of investigators 
studied and described in remai'kable detail the clinical and pathological 
consequences of food deprivation (Dmochowski and Moore, 1975). It 
was noted that in severe malnutrition minute ventilation decreased to half
■i
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of normal values and there was an increased tendency to pulmonary 
infection , including tuberculosis {'death from  starvation is death from  
pneumonia'). Most interestingly, starvation was described as causing a 
condition of 'atony of the lungs' which was thus described : ''However, 
in the few  cases where X-rays were available we could demonstrate 
radiolucency o f  the lungs, free  costophrenic angles, lowering o f  the 
lower lung borders, and decreased pulmonary mobility in the absence o f  
tubercular signs. This new syndrome o f  atony o f  the lungs , never 
described before in hunger disease, was characteristic and consistent in 
the lungs o f  our patients”. These features would now be readily 
recognised as chaiacterlstic signs of emphysema. Stein and Fenigstein, 
who canied out the autopsies, reported that findings of emphysema were 
present in 50 of the 370 cases. In 26 of those cases the individuals were 
less than 40 years of age, and the authors drew particular attention to the 
singular appearance of 'senile emphysema' in so young a population 
(Stein and Fenigstein, 1946). Even allowing for the fact that the authors 
did not define precisely their criteria for making a diagnosis of 
emphysema, these remai'kable observations were the fh’st to describe in 
any detail the link between nutritional depletion and emphysema, a 
subject which was to command tlie attention of investigators once again 
almost half a century later (Wilson et al, 1985).
25
counteipai'ts (Mortality rate: 32% in weight losing gi'oup and 16% in
i
1,2 Malnutrition and lung disease - prevalence and the 
clinical link
The fact that weight loss heralded a state of tenninal 
decline in patients with clironic airways disease was known even in the 
late 19 th. centmy (Fowler and Godlee, 1898). Although the association 
between weight loss and mortality from lung disease was thus
recognised, it was not until the 1960 s that attempts were made to
-investigate this relation. A number of studies of this period, especially
:
longitudinal studies aimed at predicting tlie prognosis of patients with of 
ah'ways disease, clearly demonstrated that a significant proportion of 
these patients suffered from malnutrition (Simpson, 1958; CaiToll, 1960; 
Lopes, 1962; Wilson et al, 1964 ). Sukmalchantra and Williams, for 
example, followed up a gi'oup of 44 patients with airways disease
f
between 1959 and 1964, performing annual tests of pulmonary function,
arterial CO2  estimation and diffusing capacity measurements 
(Sukmalchantra and Williams, 1965). They observed that 37% of these
patients lost greater than 10% of their initial weight during this 5 yeai* 
period. Not only did the group that lost weight show a more rapid 
decline in lung function and exercise tolerance, they were also more 
likely to die from their illness in compaiison with their weight stable
I
weight stable group). The Veterans Co-operative study of pulmonary 
function confinned the prevalence of malnutrition in patients with COPD 
and also presented evidence to suggest that there might be an inverse 
relation between body weight and lung function (Renzetti et al, 1966).
■li
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The mean weight of patients with a forced expired volume in 1 second 
(FEV i)  of less than 0.5 litres was 124 lb. and the mean height 68 inches 
whilst the same measures in patients with an FEV \ of greater than 1.5 
litres were 1521b. and 70 inches respectively. Vandenberg and 
colleagues (Vandenberg et al, 1966) in a study of the prognostic 
significance of weight loss showed that mortality was 30% three years 
after the onset of weight loss and 49% five years after. Only a fifth of the 
patients died without exhibiting weight loss. Investigators, following on a 
clinical impression well laid out by Domhurst (1955), began to express 
tlie opinion that changes in weight and body habitus were of more than 
just prognostic significance and that these changes had 
pathophysiological connotations. The concept that patients with COPD
.could be distinctly divided into two gi'oups - the 'pink puffers' and the 
'blue bloaters' thus aiose (Figures 1,1 and 1.2). Clinicopathological 
studies in London and Chicago of patients with COPD showed that the 
‘pink puffer’ patient suffered predominantly from emphysema whilst the 
‘blue bloater’ suffered mainly from a bronchial disease (B u ito w s  et al,
1966). Filley and his colleagues (1966), much of whose work forms the 
bulk of evidence in favour of this hypothesis, drew up the different 
characteristics of the two distinct groups of COPD patients (Table 1.1).
They obseiwed that the pink puffer, who had a lesser weight for a given 
body surface area, also had a lower oxygen consumption, even when 
expressed per unit body surface area. On the basis of cardiac 
catheterisation studies and measurements of arterial- mixed venous 0%
I
27
difference they showed that tliis type of patient had a low resting cardiac 
output and also failed to augment his cardiac output on exercise 
compaied with the blue bloater. They postulated that this inability to 
augment oxygen deliveiy and cardiac output could, in a situation 
compar able to cardiac cachexia (Pittman and Cohen, 1964), account for 
the poor nutritional status of these patients. Subsequent investigations 
(Thurlbeck WM, 1975; Nocturnal oxygen therapy trial group, 1980), 
however proved that the division of patients into two clear-cut groups 
was ratlier simplistic although more recent studies do not really show up 
this classification to be enth'ely without merit (Jamal et al, 1990). Filley 
et al’s observations on COPD patients with and without weight loss 
remain a vital piece of infonnation in this field and will be alluded to in 
subsequent discussions.
Not much interest was evinced toward the link between 
malnutrition and lung disease subsequently until the last decade when 
workers, mainly in the United States, pointed out once more the high 
prevalence and significant clinical import of malnutrition in patients with 
COPD. In contrast to the investigations of the 60s, the studies of the 80s 
and 90s that have followed the observations of these workers have 
lar gely been preoccupied with the clinical rather than the 
pathophysiological significance of nuti’itional depletion. Hunter and her 
colleagues measured nutritional status, dietary intake and immunological 
responses in 38 patients with COPD and found 27 showed evidence of 
weight loss although tlieir* mean recommended intake for 9 vital nutrients 
(and by implication their overall diet) was above the recommended daily
28
allowances (Hunter et al, 1981). Skinfold measurements revealed a
depletion of both lean body mass and fat stores although visceral protein
stores as estimated by serum albumin and transferrin were normal. Nine
of the 32 patients who underwent immunologic testing (intradeimal
injections of PPD and Candida antigens) showed anergy. The workers
concluded that malnutrition of tlie marasmic type (Blackburn and
Bisti'ian, 1974) was widely prevalent in patients with COPD. This was
followed by a report from Openbrier et al (1983) who, in a suiwey of 77
emphysematous and 30 bronchitic patients, made the important
observation that only one bronchitic patient was <90% ideal body weight
( IBW), while 43% of the emphysematous patients were below 90%
IBW. (Bronchitis was defined as FEV %/ F VC < 70%, diffusing capacity
.> 80%; emphysema as FEV % /  F VC < 70% , diffusing capacity <60%).
In the 4 bronchitic and 14 emphysematous patients who underwent 
antiiropometi'y there was a significant difference in the mid arm muscle 
ch'cumference and tiiceps skinfold thickness between the two groups, 
with the emphysema gi’oup exhibiting significantly lower values. In the 
emphysema group there were significant coiTelations between nuti’itional 
measures and lung function. For the first time measures of respiratory 
muscle function were made (Peak inspiratory and expiratoiy pressures, P
I max. and P E max.) and these showed that inspiratory muscle weakness 
was evident in 9 of the emphysema patients but none of the bronchitlcs, 
even after allowing for the mechanical disadvantage caused by 
hyperinflation in the emphysema gi'oup (Table 1.2).The authors proposed
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that the impainnent of lung function in COPD may be in part due to the 
effects of nutritional depletion on respiratory muscle mass and activity, a 
theory which was to attract much attention in subsequent years. A few 
other subsequent studies confirmed the prevalence of malnutrition in 
COPD patients, with one particular study examining the incidence of 
malnutrition in an outpatient population to avoid the confounding effect 
of acute illnesses that hospitalised COPD patients may exhibit (Braun et 
al, 1984). This study too confirmed that a significant proportion of 
patients with COPD who were not acutely unwell were malnourished 
(weight loss in 27%; TSF < 60% in 33%). Wilson , Rogers and Hoffman 
in an extensive review of the link between nutrition and chronic lung 
disease (1985) summaiised these and various other studies and 
concluded "malnutrition is a common problem with patients COPD, so 
tliat nutritional assessment including anthropometric measures as well as 
inspiratory and expiratory pressures, should be included in the evaluation 
of patient with suspected nutiitional impairment ",
Perhaps the most comprehensive and informative study 
linking nutritional status and the course of COPD was a retrospective 
analysis of the National Institutes of Health Intermittent Positive 
Pressure Breathing Trial (Wilson et al, 1989). Data collected from a 
three yeai* clinical tiial assessing the effect of intennittent positive 
pressure ventilation (Intermittent Positive Pressure Breathing Trial 
Group, 1983) was used to detect the relation between body weight, 
pulmonary function and mortality in 779 men ( women were not analysed 
as they were fewer in number and had a different distiibution of weight
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from the men). The population was divided into cohorts on the basis of 
degree of airflow obstruction (mild, moderate, severe) and percentage 
ideal body weight based on the Life Insurance Company Standards (New 
York, Meti’opolitan Life, 1983). Mortality over the three year period was 
influenced by body weight in all three groups of aiiflow obstruction 
(Figure 1.3). In patients with FEV% <35%, mortality increased with 
decreasing body weight (p =0.093). In patients with FEV j 35-47% the 
relation was stronger (p = 0.048), while in patients with FEV% > 47% it 
was even sti’onger (p = 0.007).In other words, the relation between low 
body weight and mortality was strongest in those patients who did not 
particulaiiy suffer from severe aiiflow obstruction. Another important 
finding of the study was that body weight was a powerful predictor of 
diffusing capacity in patients with same FEV j (p=0.0001). After 
adjustment for FEV \ body weight correlated positively with exercise 
capacity (p = 0.0001). The study, its retrospective nature 
notwithstanding, was an authoritative confirmation, if one was required, 
of the importance of the link between nutritional status and morbidity 
and mortality from lung disease.
Another significant study highlighting the problem of 
nutritional depletion in COPD patients came from the Dutch group 
(Wouters and Schols, 1993). These investigators assessed the body 
composition of a group of 255 patients with moderate COPD (mean 
FEV I 35% predicted) who were pait of a pulmonary rehabilitation 
programme . Arguing that body weight is not a sensitive measure of 
nutritional status or body composition, they estimated fat free mass
■=i
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patients too were depleted of FFM (Figure 1.4). These normal weight 
patients with low FFM exhibited greater physical impairment than 
underweight patients with preserved FFM. It appears from this recent 
and important study that malnutiition may be more widespread a 
problem than hitherto believed.
1.3 Pathogenesis of malnutrition in patients with COPD
Although malnutrition has been recognised as a significant 
problem in patients with COPD, attempts to elucidate the underlying
(FFM) in these patients using the bioimpedence technique (Lukaski,
1987). Classification of patients on the basis of body weight and fat free 
mass revealed that not only did underweight patients show evidence of 
depletion of FFM but that a significant proportion of normal body weight
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pathophysiology of this phenomenon have been few. While a large 
number of centi'es have been involved in providing nutritional support to
these patients, only a handful have adopted a scientific approach to the 
problem. This is particulaiiy unfortunate as considerable effort and 
resources ai'e being deployed on supplementaiy feeding programmes 
which have, as we shall see, bestowed very little benefit. This was 
highlighted by Koretz (1985), who observed with regard to nutritional I
tlierapy," The enthusiastic embracement of this therapy is based largely 
on the notion that patients must do better when they are fed than when 
they ai’e not, an attitude that does my grand mother's chicken soup 
philosophy proud".
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The following section summaiises the various theories that have 
been proposed to explain the occunence of malnutrition in COPD 
patients.
1.3.1. Decreased intake
The earlier investigators of the relation between 
malnutrition and COPD were of the belief that weight loss resulted from 
persistent anorexia, a common complaint amongst patients with COPD 
(Browning and Olsen, 1961; Wilson et al 1964). Vandenberg et al in 
tlieü' oft cited paper on mortality rates in different subpopulations of 
COPD, stated that weight loss probably resulted from diminished caloric 
intake. In their study there was indeed a difference in the caloric intake 
between patients with and without weight loss (Vandenberg et al, 1967). 
It must be pointed out that most of these studies employed methods of 
random recall and other methods of dietary assessment that would be 
considered inaccurate in the present day (Bingham et al, 1994).
Moreover even in the patients studied there was a wide range of dietary 
intakes with some patients in the weight losing group apparently 
consuining more than those in the weight stable group. In any case, 
subsequent studies have not confirmed the conclusions of these 
investigators. In a study compaiing the food intake of hypercapnoeic, 
overweight patients and malnomished, normocapnoeic patients, Semple 
at al found no difference in dietary intake between the two groups 
(Semple et al, 1979). Braun et al (1984), in their study of 60 outpatients 
with COPD, assessed the diet of the patients by written records and
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concluded that caloric intake was adequate at 156% predicted basal 
energy expenditure, although it was speculated that this intake might not 
allow for increased activity and might thus, conceivably result in weight 
loss. Schols and her colleagues measured dietary intake by dietary history 
(validated in this patient group by a previous study, Schols et al, 1990) in 
80 patients with stable COPD who were divided into a weight losing and 
a weight stable group. Absolute dietary intake was lower in the weight 
losing patients while absolute resting energy expenditure was comparable 
in the two groups. When subgroup analysis was based on severity of 
disease it was found that in the less compromised group , a moderate 
proportion of the patients had an increased REE but this was matched by 
an increased intake such that there was no weight loss. With increasing 
airflow obsti’uction there was a gieater elevation of REE but dietary 
intake did not always increase, resulting more frequently in weight loss in 
this group. In the most compromised group not only was REE much 
elevated, but dietai'y intake had also dropped, resulting in pronounced 
negative balance and weight loss. In an attempt to explain these findings 
the same investigators measured transcutaneous oxygen saturation and 
carbon dioxide tensions during meals and concluded that breathlessness 
caused by the effort of eating does not explain weight loss in 
normoxemic COPD patients but may contiibute to limited intake in 
patients who were akeady hypoxemic (Pa O2  < 7.3 kPa), echoing the 
findings of a previous study (Brown et al, 1983). The conclusion that 
emerges from these studies is that the more severely compromised the
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COPD patient, the greater his/ her weight loss and the less his dietary 
intake. This, of course, does not imply that weight loss is the 
consequence solely of a decreased dietary intake. It appears likely that 
decreased dietary intake, whilst contiibuting to weight loss once the 
process has started in association with severe disease, is not the initial 
cause of weight loss.
Other theories postulating decreased dietaiy intake, for 
example as a result of increased incidence of peptic ulcer disease in 
emphysema patients (Latts EM et al, 1956; Zasly et al, 1960), have not 
been substantiated.
1.3.2. Variations in hormonal response to hypoxia.
Investigations exploring the hormonal response to COPD 
were prompted by the obseiwations of Pugh (1962) and Campbell (1975) 
that hypoxia inhibited adrenal and gonadal function and could cause 
weight loss. Marmorston et al (1966) drew attention to the abnormal 
minaiy hormonal profile of patients with emphysema and cancer. These 
results were followed up by Semple et al who compared the steroid 
hormone profile of sixteen patients with two distinct types of COPD, the 
‘pink puffer’(PP) and ‘blue bloater’(BB) alluded to in previous 
discussions (Semple et al, 1979). The ‘blue bloaters’ were all 
hypercapnoeic whilst the ‘pink puffers’ group were normocapnoeic.
They found that whilst seven of the eight BB group were overweight, 
seven of the eight PP gi'oup were underweight. The hypercapnoeic BB
%
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group showed significantly depressed testosterone levels and the authors 
speculated whether the increased weight in the BB group was the result 
of low testosterone levels. However there was no convincing explanation 
for the occurrence of weight loss in the normocapnoeic PP group and the 
theory invoking a hormonal basis for weight loss in COPD remains 
unproved.
1.3.3. Weight loss as the result of tissue hypoxia
As previously mentioned, Filley and his colleagues studied 
the physiologic differences between two distinct subtypes of COPD 
patients (Filley et al, 1968) and showed that the poorly nourished 
emphysematous patient was chai'acterised by a low resting cardiac 
output, near normal arterial oxygen saturation (Sa O2 ), a high ventilation 
to cardiac output ratio in contr ast to the bronchitic type of patient who 
exhibited a normal cardiac output, a low Sa O2  and a low ventilation to 
cardiac output ratio. Whilst resting oxygen arterial tensions were higher 
in the thin, emphysematous patient, tissue oxygenation, as estimated by 
the ratio of oxygen delivered (cardiac output x aiterial oxygen content) 
to the oxygen consumed (aiterial - mixed venous oxygen content) was 
better in the plethoric, bronchitic patient. They hypothesised that the 
muscle wasting of the emphysematous patient was really the result of 
tissue hypoxia, secondary to low cardiac output and that a high caidiac 
output, in the presence of a destroyed pulmonary vascular bed (the 
underlying pathology of emphysema) would in fact not only increase the 
load of the right venti'icle but would also reduce the time which the
:
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blood spends in the capillaries. They speculated that with a restricted 
caidiac output the emphysematous patient was increasing the pulmonary 
transit time, thus avoiding dangerous hypoxemia. They asked, " Is not 
tlie low caidiac output and high ventilation the only way a PP patient has 
available to supply adequate oxygen to his tissues ?". It is smprising that 
this entirely plausible explanation based on painstaking experimental data 
has not been the subject of further research.
1.3.4. Increased energy cost of breathing
Under normal ckcumstances the energy cost of ventilation 
(i.e. the oxygen consumption of the respiratoiy muscles) is very low, 
amounting to no more than 5% of the body's total oxygen consumption 
(Millie- Emili and Petit, 1960). Whilst it was widely believed that this 
oxygen cost of breathing (OCB) would be increased in patients with 
COPD due to increased airways resistance, it was Cherniack who first 
demonstrated this to be tlie case (Cherniack, 1959). Measuring OCB by 
adding dead spaces to die breathing circuit he showed that whilst the 
cost of increasing ventilation by a liti*e in noimal subjects was 1 - 2  mis 
of 0% /  mill, in COPD patients this value was 6 - 1 1  mis of 0% /  min. 
These observations have since been confirmed by other investigators 
(Levison and Cherniack, 1968; Field et a l , 1982; Donahoe 1989). 
Wilson, Rogers and Hoffmann (1985) proposed the tiieory that this 
increased oxygen cost of breathing resulted in a state of increased resting 
energy expenditure and, this in the face of normal or decreased 
nutritional intake, led to weight loss. In keeping widi this theoiy was the
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with and without weight loss noted that the OCB was significantly 
elevated in patients with weight loss compared to those without and that 
there was a significant correlation between OCB and REE. This was
finding of many investigators that resting energy expenditure was indeed 
elevated in patients with emphysema (Goldstein et al, 1987, 1988; 
Wilson et al, 1990; Schols et al 1991). To account for the fact that 
weight loss was not a feature of patients with bronchitis who had similar 
degree of airflow obstruction, and by implication a similai' increase in 
work load, the proponents of this theory put forward two 
complementary explanations: (1) Although patients with emphysema and 
bronchitis have equal levels of airflow obstruction, patients with 
emphysema show a gi’eater tendency to hyperinflation (greater ratio of 
residual volume to total lung capacity) and that this results in flattening 
of the diaphragm, and therefore a loss of efficiency of the muscle due to 
a shift to the less efficient portion of the force- length relationship 
(Roussos and Macklem, 1977). This loss of efficiency leads to increased 
energy consumption by the respiratory muscles and raised REE and 
weight loss. (2) In contrast to bronchitic patients, emphysematous 
patients showed evidence of respiratory muscle weakness (Openbrier et
al, 1983). It was postulated that the increased work of breathing caused 
respiratory muscle fatigue which in turn rendered the muscles even more 
inefficient, setting up a vicious circle of worsening efficiency and 
increasing oxygen consumption ultimately resulting in weight loss 
(Figure 1.5).
Donahoe et al (1989) in a study of emphysematous patients
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shown as evidence to support that raised OCB was the reason for weight 
loss and malnutrition in patients with emphysematous COPD. The Dutch 
workers also provided evidence from a larger study to show that 
emphysematous COPD patients with weight loss have an elevated REE 
and that this results in a state of negative energy balance and weight loss 
(Schols et al, 1991). It is in this regard a recent paper from another 
group of workers is interesting. Ryan and co-workers (1993) measured 
caloric intake, REE and the thermogenic effect of food in 10 
malnourished COPD patients ( < 85% IBW) in a clinically stable state. In 
contrast to the other previous workers they found that REE was 94 ± 
16.5% of values predicted by the Harris-Benedict equation (Harris and 
Benedict, 1919). Refeeding caused a large increase in energy expenditure 
(24 + 18  %). They concluded from their study that stable COPD patients 
were in fact not hyper metabolic and consumed enough calories to meet 
average requfrements, but that the thermogenic effect of a meal was 
considerable, as noted by previous investigators (Goldstein et al, 1987). 
In an attempt to explain the variance of their findings from those of 
previous investigators, the authors suggested that methodological 
differences (use of a non-invasive canopy system rather than an invasive 
mouth- piece plus nose clip system to measure REE) may have been 
responsible for the lower values for REE (Askanazi et al, 1980). This, 
however is not an entirely satisfactory explanation, as other workers 
(Schols et al, 1991) also used a non-invasive canopy system to estimate 
REE and have demonsh'ated elevated values.
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Ryan and co-workers are not the only investigators to show 
that hyper metabolism is not a consistent feature of emphysematous 
COPD patients. Green and Muers (1992) measured REE by indirect 
calorimetry using a ventilated canopy in six emphysematous patients, 
eight chronic asthmatic patients, nine non-smoking related COPD 
patients and six controls. All controls, four out of six emphysema 
patients, five of nine hypercapnoeic COPD patients and three of eight 
asthmatics had REE witliin 10% of the predicted values (Harris-Benedict 
equation). The study also showed that a given patient’s metabolic state 
could not be predicted from lung function tests or arterial blood gas 
analysis.
It is noteworthy that although the increased energy cost of 
breathing is postulated to result in a state of hyper metabolism and 
weight loss, very few attempts have been made to study the energy 
balance of patients with lung diseases other than emphysema to detect 
whether or not the increased work of breathing in the context of other 
lung diseases can influence energy balance adversely. Fitting et al (1990) 
studied a heterogeneous group of 12 patients with interstitial lung 
disease due to a variety of causes ranging from sarcoidosis to silicosis 
and found that REE was elevated by 17 - 21% above predicted values. 
Their contention that this elevation was the result of increased work of 
breathing did not however explain the reason for the lack of relation 
between lung function and elevation in REE and the autliors admit that 
other mechanisms, including ongoing inflammation could account for the 
elevated REE. There have been no studies of patients with other types of
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of lower respiratory ti’act infection or any other intercurrent illness
:
irespiratory impairment without accompanying inflammatory phenomena, |
Îfor example those with disease of the chest wall like scoliosis, who have 
a maiked increase in the work of breathing (Kafer, 1975; Jones et al 
1981). This issue is the focus of detailed attention in a later chapter of 
this thesis.
1.3.5. Thermogenic effect of food
Total energy expenditure is the sum of REE, die energy 
cost of physical activity and the thermogenic effect of nutrients (diet
induced thermogenesis). There is some evidence to suggest that diet 
induced thermogenesis (DIT) is elevated in patients with emphysematous 
COPD (Goldstein et al, 1987; Ryan et al, 1993; Green and Muers, 1993), 
although more recent studies show evidence to the contrary (Hugli et al, 
1993). Even if DIT is increased in COPD there is no evidence to suggest 
that this increase in DIT is any different from tliat following refeeding in 
other states of malnutrition (Piers et al, 1992) or that this state of 
elevated DIT precedes and is responsible for weight loss.
1.3.6. Influence of concurrent illnesses.
Bates (1973), in an interesting lecture brought togetlier the 
vaiious clinical and pathophysiological observations pertaining to 
patients witli COPD and attempted to provide an explanation for weight 
loss in these patients. He suggested that in patients with COPD, episodes f
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results not only in an increase in the energy needs of the individual but 
also a decrease in food intake, thus causing net negative energy balance 
and weight loss (Figure 1.6). The theory however fails to provide an 
explanation as to why patients with chronic bronchitic type of COPD, 
who have as many or more episodes of infection, do not show a tendency 
to lose weight, whilst emphysematous COPD patients do.
1.3.7 Drug therapy
Air flow obstruction in COPD is treated with inhaled beta- 
adi'energic agents like salbutamol and terbutaline. Although these drugs 
ai'e prescribed to be used on an as required basis, most COPD patients 
use these drugs regulaiiy. It is known that adrenergic drugs cause a dose 
dependent increase in energy expenditure (Fellows et al, 1985). More 
recently, studies have demonstrated that inhaled salbutamol, even in 
small doses, cause an appreciable increase in REE (Amoroso et al,
1993). Given that COPD patients use a considerable amount of beta 
agonists for symptom relief it is possible that the thermogenic effect of 
these drags may have an adverse influence on the energy balance of these 
patients and leads to weight loss.
1.4 Malnutrition and cystic fibrosis
Any account of tlie link between malnutrition and lung 
disease would be incomplete without a reference to cystic fibrosis. Cystic 
fibrosis (CF) is an autosomal recessive genetic disease of the exocrine
(3) Parenteral nutiitional support may improve pulmonary function (Levy 
et al, 1985), although this is not always the case (Shepherd et al, 1988).
Whilst the pathogenesis of the nutritional abnormalities in 
CF is different from that in COPD, the significant influence of nutrition
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glands that predominantly affects the lungs and the pancreas. The genetic 
abnormality leads to failure of synthesis of a protein vital to the transport 
of electrolytes across the cell membrane, resulting in the production of 
viscid secretions that obstruct the ducts of the glands. The first 
manifestation of the disease is often meconium ileus, i.e., obstruction of 
the intestine by thick, inspissated stool. Chronic pulmonary sepsis, 
pancreatic insufficiency and focal biliary cirrhosis occur gradually leading 
to respiratory failure, malabsorption and malnutrition. The pathogenesis 
of malnutrition that is associated with CF is distinctly different from that 
associated with COPD in that it is the result, not primaiily of a 
pulmonaiy pathology, but of the pancreatic abnormality associated with 
the disease leading to malabsoiption. Nevertheless some of the 
nutritional aspects of CF are worthy of note.
(1) Although the prognosis of CF is primarily related to pulmonaiy 
function, poor nutritional status (as measured by anthropometry) is 
associated with a worse prognosis (Kraemar et al, 1978).
(2) Resting energy expenditure is elevated in CF, and falling REE has 
been shown to be a more sensitive indicator of clinical improvement from 
an acute exacerbation of the disease than pulmonary function tests and
I
chest radiographs (Naon et al, 1993).
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on the course of CF underscores the importance of the relation between 
nutritional status and lung function in patients with chronic lung disease.
1.5 Diet composition and respiratory function
The previous sections of this review have been concerned 
primarily with the effect of respiratory dysfunction on the nutritional 
status of a patient. There is however another aspect of the relation 
between nutrition and respiratory dysfunction that merits attention. This 
is the effect of dietary composition on gas exchange and respkatory 
function.
Energy for the sustenance of vital functions of tlie body is 
obtained by the combustion of proteins, carbohydr ates and fats in the 
diet. In this process of combustion, oxygen is consumed and carbon
' T:dioxide produced. The ratio of carbon dioxide produced to oxygen 
consumed is termed the Respiratory Quotient or RQ. The RQ of the 
three sources of energy are : fat : 0.7, carbohydrate : 1.0 and protein 0.8. 
The implication of the different Respiratory Quotients is that during the 
metabolic process more carbon dioxide is produced per amount of 
oxygen consumed if the metabolic fuel is carbohydrate than if the fuel is 
fat. In healthy individuals the ingestion of a large carbohydrate load 
results in increased CO2  production but increase in minute ventilation 
ensures that this increased CO2  is expired and that arterial tensions of 
CO2  do not rise (Saltzman and Salzano, 1971). The situation is however 
different in patients who have a limited respkatory reserve and cannot
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increase their ventilation. Attention was first drawn to this as a clinical
_problem in the intensive care setting where acutely unwell patients were 
reported to have developed respiratory failure following parenteral 
feeding with high glucose loads (Askanazi et al, 1980 ii). The possible 
negative impact of high carbohydr ate diets on patients with limited 
respiratory reserve had been studied earlier by Gieseke at al (1977) who 
fed 13 patients with aiiflow obstruction a high carbohydrate diet and 
monitored its ventilatory effects. As expected there was an increase in 
minute ventilation, CO2  production and O2  consumption. However there 
was no increase in aiterial CO2  tension in patients who were 
nonuocapnoeic and a small, statistically insignificant increase in CO2  
tensions in hypercapnoeic patients. The authors concluded that an 
increased carbohydrate load was generally well tolerated by patients with 
clrronic airways disease. These findings were refuted by Angelillo et al
(1985) in their study of 14 ambulatory patients with COPD. In this study,
•Ipatients were given three diets: low carbohydrate, high fat (28% 
carbohydrate, 55% fat), a moderate carbohydrate, moderate fat ( 53% 
carbohydrate, 30% fat), high carbohydrate, low fat (74% carbohydrate,
9.4% fat). Each diet was administered as a liquid in a randomised double 
blind manner for 5 days. Daily measurements of O2  consumption, CO2  
production , arterial P O2 , aiterial P CO2 , tidal volume, respiratory 
frequency and minute volume were made. FEV \  and F VC were also 
determined at the beginning and end of each 5 day period. The 
investigators found that whilst O2  consumption did not vary between the
1
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diets CO2  production and arterial CO2  tensions were lower on the low 
and moderate carbohydi'ate diets. (A significant and unexplained finding 
of the study was that, despite a caloric intake greater than estimated 
requirements there was a statistically significant weight loss in the group 
as a whole!). The study thus suggested that a diet restricted in 
carbohydrate content may be beneficial to patients with chronic airways 
disease. Brown et al (1985) extended tliis line of investigation further and 
studied the effects of a carbohydrate load on the exercise capacity of 
patients with chronic ah'ways disease. Compared with a placebo diink, a 
cai'bohydiate drink (480 ml giape juice + 150 g sucrose; 980 kcal) 
resulted in a decrease in maximal power output during exercise although 
maximal ventilation at exhaustion was nearly identical. At equivalent 
power outputs the cai'bohydrate drink resulted in a significant increase in 
minute ventilation and CO2  output. However there were no changes in 
aiterial CO2  tensions although Pa O2  during exercise was higher after 
carbohydrate loading. Subsequent studies of the influence of diet on 
exercise tolerance in patients with COPD have compared carbohydrate 
and fat based diets on exercise capacity and have concluded that 
cai'bohydrate rich diets not only decrease exercise capacity but also 
increase the sensation of breathlessness (Efthimiou et al, 1992; Kuo et ai, 
1993).
In conclusion, carbohydrate rich diets appeal' to have an 
adverse effect on ventilation and exercise capacity in patients with limited 
respkatoiy reserve due to chronic airflow obstruction. W hether dietary 
manipulation by increasing the proportion of calories obtained from fat
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will improve morbidity and mortality in patients with chronic respiratory 
impainnent remains unknown. This thesis will not address further this 
issue of diet composition and respiratory function.
1.6 Clinical implications of malnutrition - refeeding studies
The logical consequence of identifying malnutrition as an 
adverse prognostic factor in COPD patients was the attempt to improve 
prognosis by improving the nutritional status of these patients. With 
nutritional depletion being clearly associated with poorer lung and 
respiratory muscle function, it appeared entirely appropriate to reverse 
the negative trend by nutritional repletion. However, the results of such 
refeeding studies have been, at best, equivocal and at worst extremely 
disappointing. Wilson and his colleagues, whose significant work in tliis 
field has akeady been alluded to (Wilson et al, 1985), were the fkst to 
report the results of a study of nutritional supplementation in patients 
with COPD. In an uncontrolled study involving six patients with a mean 
body weight which was 75% of values predicted (75% IBW), they 
demonstrated an increase in weight, anthropometric measures (TSF, mid­
arm muscle ckcumference(MAMC)) and peak inspiratoiy and expiratory 
pressures after 2 weeks with a dietary intake of 1.5 times BMR (Wilson 
et al, 1986). Likewise, in a controlled study, Goldstein and co-workers 
showed a 10% improvement in peak inspkatory and expiratory (P I  and 
PE max) pressure values over a two week period on a diet providing 
calories to the amount of 1.7 times measured REE (Goldstein et al.
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1988). Similai' findings were also reported by Whittaker et al (1990) in a 
study of nutritional supplementation (nasoenteric feeding) in 10 
malnourished patients with COPD. Whilst the aforementioned studies 
were all peifonned in the suiToundings of a clinical research unit, 
Efthimiou and colleagues extended the investigations to the outpatient 
setting in their study of a nutiitional support programme in 14 
malnourished and 7 well nourished COPD patients (Efthimiou et al,
1988). Subjects were studied over a nine month period. After a 3 month 
baseline period tlie malnourished COPD patients were randomised to 
receive nutiitional supplementation or continue them regular diet for 3 
months. At the end of tlie 3 months the supplementation gioup returned 
to their usual dietary habits. The well nourished COPD gioup were on 
their usual intake for the eiitke nine month period. Tests of respiratory 
muscle function (including sternomastoid fatiguability), spirometry, 6 min 
walking distances, quality of life assessments and anthropometric 
measurements were perfonned at 3 monthly inteiwals. During tlie entire 
study dietai'y supei'vision was close and intensive, with an increase in the 
caloric intake of the supplementation group amounting to 48% over their 
original intake. In the gioup which received nutritional supplementation 
the weight gain over the 3 month period of supplementation was 4.2 kg 
(range 0.7 - 8.2 kg). Weight gain was associated with significant 
improvements in sternomastoid and handgrip strength, 6 min walking 
distances, well being scores and decreased sternomastoid fatiguability. 
Interestingly all these measures tended to return to the original abnomial
48
levels on return to the usual diet. The conclusion was that a well 
supervised outpatient nutritional support programme was capable of 
producing an improvement in the clinical condition of malnourished 
COPD patients.
However, tliese encouraging findings have not been 
confirmed by other observers. Lewis et al (1987), in a randomised study 
of 21 malnourished COPD patients showed that there was no significant 
improvement in weight, antlii'opometric measures, respiratoiy muscle 
stiength or endurance after 8 weeks of nutritional supplementation. The 
investigators made the important observation that subjects limited their 
caloric intake from the usual dietaiy sources whilst on supplements and 
for this reason theii* overall caloric intake whilst on supplements rose 
only by 15%. These findings were essentially confirmed by Knowles et al 
(1988) who performed a randomised, crossover study in 25 COPD 
patients. Caloric intake which increased by a mean value of 28% over 
baseline values after 4 weeks of supplementation, was only 18% above 
baseline intake at the end of 8 weeks. Weight gain and improvements in 
respiratoiy muscle sti'ength were noticeable only in those subjects who 
had increased their intake by more than 30%. The impression that 
nutritional supplementation per se was of limited value was reinforced by 
a well designed , placebo controlled, randomised, double blind study 
conducted by a gi'oiip of Danish investigators (Otte et al, 1989). Only 13 
of a group of 28 patients who were given supplements for 13 weeks 
increased their weight by mean of 1.5 kg weight whilst the contiol group 
gained 0.16 kg. No differences were observed in the pulmonary function
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or immunologic status (T-helper/suppressor ratio, mitogen reaction of T 
lymphocytes to phytohaemagglutin ).
Perhaps the most comprehensive of tlie refeeding studies 
is the more recent investigation of Rogers and his colleagues (1992), in 
which 15 malnourished COPD patients and 12 controls well matched for 
nutritional status and lung function were studied. Intervention comprised 
of a nutritional supplementation programme providing calories 1.7 times 
REE with approximately 1.5 g /  kg of protein daily for a period of 3 
weeks. The intervention gi'oup was admitted to a clinical reseaich unit 
for this purpose. Anthropometiy, lung function tests (spirometiy, 
diffusing capacity, respiratory muscle strength), 12 min walking tests, 
handgrip strength and biochemical tests were perfonued at weekly 
intervals for the 3 weeks prior to randomisation and again 1 and 4 
months post randomisation. The intervention group showed a significant 
weight gain (+2.4 kg vs - 0.5 for control), improved hand grip strength, 
expiratory muscle strength and walking distance after the 4 month 
period. It was noted that the weight gain achieved in the intervention 
group during their initial 4 week stay in the research unit could not be
■:'ir
sustained in the outpatient environment despite tlie provision of full and 
intensive nutritional support. The authors concluded that whilst under 
conti'olled conditions refeeding resulted in significant improvements in 
some measui’es of respiratory function, nutritional therapy was ‘costly, 
time - intensive and of limited therapeutic magnitude’.
In sumiuaiy (Table 1.3), nutritional repletion by intensive 
refeeding techniques, whilst logical and attiuctive, appears to of limited
L
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value in the management of malnourished patients with COPD. 
Significant weight gain is clearly associated with some improvement in 
respiratory muscle function, exercise capacity and general well being; 
however achieving a weight gain in this group of patients requires 
intensive and expensive techniques which are clearly not sustainable in 
the long term. At the time of writing of this review no study has 
addressed the issue of whether long term nutiitional supplementation has 
an effect on mortality and morbidity in malnourished COPD patients.
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1.7 Conclusions
1. Weight loss is a frequent complication of end stage chronic 
obstructive pulmonary disease,
2. The presence of signs of nutritional depletion is associated with a 
greater morbidity and mortality from the disease.
3. Malnutiition is a feature of emphysematous but not chronic bronchitic 
type of COPD; malnutiition appears to be more closely related to the 
pathophysiological confiâtes of emphysema (abnormal gas exchange) 
rather than airflow obstiaiction per se .
4. Poor nutiitional status has a negative impact on respiratory muscle 
function and this issue may be crucial in the overall relation between 
malnutrition and lung function and clinical outcome.
5. The cause of malnutrition in patients with emphysema remains uncleai*. 
The theory that has attracted most attention suggests that weight loss 
results from a state of negative energy balance following from the higher 
energy requirements of the fatigued respiratory muscles (increased work 
of breathing) in the face of normal or reduced nutrient intake. Other 
possible explanations, not mutually exclusive, include:
(a) a state of stepped decline in body weight and lung function 
occasioned by hypermetabolism and anorexia during intercurrent illnesses 
like lower respkatoiy tract infections ultimately leading to malnutrition;
(b) destiuction of the pulmonaiy vascular bed due to emphysema results 
in an inability of the cardiopulmonary system to provide tlie nutritional 
and oxygen demands of the tissue resulting in nutritional depletion;
52
(c) drug (beta-adrenergic agents) induced themriogenesis contributing to 
a state of hyper metabolism and negative energy balance.
6. Attempts at improving the nutritional status of malnourished COPD 
patients, even by intensive hospital based nutritional supplementation 
programmes, have achieved only limited success.
1.8 Aims of the thesis
The main aim of the investigations that comprise this thesis was 
to illuminate some of the aspects of the relation between lung function, 
energy balance and nutritional status of patients with respiratory 
impaiiTTient. This was achieved by a series of studies which addressed the 
following hypotheses and specific questions :
1. Severe respiratoiy dysfunction and by implication, increased work o f  
breathing, increases resting energy expenditure in patients with lung 
disease.
Do all patients with an increase in the work of breathing due to lung 
disease exhibit an elevation of resting energy expenditure? For example, 
is resting energy expenditure elevated in patients (not previously studied) 
with chest wall defomiities due to scoliosis and thoracoplasty which aie 
chai'acterised by a mechanical inefficiency of the thoracic cage?
2. Increased resting energy expenditure in patients with lung disease is 
related to an increase in the oxygen cost o f  breathing and leads to 
increased resting energy expenditure, negative energy balance and poor 
nutritional status.
I
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What is the relation between the energy or oxygen cost of breathing, 
lung function, resting energy expenditure and nutiitional status in 
patients with chest wall disease and in patients with emphysema? Is there 
a direct relation between poor lung function, increased oxygen cost of 
breathing and elevated resting energy expenditure and poor nutritional 
status?
3. The recognised thermogenic effect o f  beta agonists contributes to the 
state o f  negative energy balance and weight loss in patients with lung 
disease.
What is the effect of inhaled beta agonist drug therapy on resting energy 
expenditure in respiratory patients who are long term users of the drug? 
Is it possible that the thermogenic effect of beta adrenergic agents 
documented previously in nonual healthy subjects, contributes to a state
of negative energy balance and weight loss in COPD patients?
4, Negative energy balance suffered, during an acute infective 
exacerbation o f chronic lung disease contributes to a state o f  
malnutrition inpatients with COPD.
What is the exact energy cost of an acute infective exacerbation in 
patients with COPD? Do nutr itionally depleted and well nourished
COPD patients differ with respect to their thermogenic response to Iinfection?
A subsidiar y aim of the research project was to assess the 
efficacy of routine and novel methods of therapy in improving the 
nutritional status of malnourished patients with COPD. One study 
addressed the question whether the relative success achieved by intensive i
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supplementation programmes in improving the nutritional status of 
COPD patients could be matched by routine outpatient dietary 
programmes provided as a clinical service. A further pilot study explored 
tlie use of Clenbuterol (a beta agonist drug with muscle performance 
enhancing properties) in conjunction with nutritional supplementation in 
improving nutritional status and muscle mass in underweight COPD 
patients.
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1.9 Layout of the thesis
The literatui'e in the field of nutrition and lung disease with pai'ticulai' 
reference to the links between energy balance, nutritional depletion and 
lung function, is summaiised in Chapter 1 The chapter ends with a 
section on the aims of the thesis.
The var ious methods of measurement employed in the study, particularly 
of nutritional status and energy expenditure (calorimetry) are outlined in 
Chapter 2. The chapter also presents the results of a study comparing a 
ventilated hood system with a mouth piece and nose clip system to
a%
measure resting energy expenditure in patients with severe lung disease.
The investigations exploring the relation between resting energy 
expenditure and respii'atoiy impainirent begin in Chapter 3, which 
reports the results of a study of resting energy expenditure in a group of 
patients with chest wall deformities, a condition known to be associated 
with an increase in the energy cost of breathing.
Chapter 4 extends the studies of the previous chapter to make direct 
lueasurements of the oxygen cost of breathing and compares tlie oxygen 
cost of breathing and its relation to lung function, nutritional status and 
resting energy expenditure in patient groups with respiratory impairment 
due to scoliosis, thoracoplasty and emphysema.
A study assessing the impact of inhaled beta agonist therapy (salbutaiuol) 
on the resting energy expenditure of patients who ar e long term users of 
the drug constitutes Chapter 5.
I
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this chapter attempts to provide a unified view of the link between 
energy balance, nutrition and respiration; the concluding section 
highlights areas of research for future studies in this field.
Chapter 6 quantifies the energy deficit suffered by patients with COPD 
during an acute exacerbation of the disease; results aie presented of a 
study in which resting energy expenditure and dietary calorific intake 
were measured on admission and at the time of discharge in patients 
hospitalised witli an acute lower respiratory tract infection.
Chapter 7 presents the experience of the investigator in clinical studies 
aimed at improving the nutritional status of patients with chronic lung 
disease. A section is devoted to a pilot study of Clenbuterol, a beta 
adi’energic agonist which has, in addition to bronchodilator properties, an 
ability to alter body composition and muscle strength favourably. 
Chapter 8 brings together the results of the vaiious studies and reviews 
other studies in the field that have been published during the time when 
tlie investigations that comprise this thesis were in progress. A section of
I
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PIN K  PU FFER BLUE BLO A TER
Thin in appearance; frequent history No history of weight loss except
of loss of weight. terminally.
Narrow cardiac shadow on chest Significant cardiac enlargement.
radiograph
No history of congestive heart Frequent episodes of heart failure
failure until terminally which respond to treatment.
Heamatocrit less than 55% Haematocrit greater than 60%
Low V O 2  per squai'e metre body High V O2  per square metre body
surface ai'ea surface area
High resting ventilation Low resting ventilation
Low cardiac output; inability to Normal cardiac output
augment cardiac output during
exercise
High Sa O2 Low Sa O2
Bronchial mucosal gland Bronchial gland hyperplasia
hypeiplasia not prominent (2 /1 0 prominent ( 7 / 1 0  patients)
patients)
Emphysema in all 10 patients Emphysema in 8/ 10 patients
i
Table 1.1: The differences in the clinical and pathophysiological 
features of the two different subtypes of patients with COPD . From 
Filley eta l, 1968.
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All values as mean ± standard deviation.
* Values as % predicted.
** p < 0.05
Table 1.2 : Anthropometric measures and lung function in patients with 
chronic bronchitis and emphysema highlighting the nutritionally depleted 
state of emphysematous patients. From Openbrier et al, 1983.
Clironic Bronchitis (n=4) Emphysema ( n=14)
Age 62 ± 4 .2 57 ± 5 .1
Forced vital capacity* 98 ±  29.5 82 ± 2 1 .9
FEY 1 * 57 ± 17 .3 35 ± 1 6 .6  **
FEY 1 / FYC * 47 ± 11 .5 33 ± 1 0 .2  **
Total lung capacity * 102 ± 1 7 .4 106 ± 12 .7
Diffusing capacity * 135 ±19.1 32 ±  16.4 **
Peak inspiratory 
pressure
> 60 cms in all patients < 60 cms in 10 /  14 
patients
Peak expiratory 
pressure
> 60 cms in all patients < 6 0  cms in 6 /1 4  
patients
% Ideal body weight 124 ± 13 .2 88 ±15.1  **
Ann muscle 
circumference *
125 ± .3 7 91 ±  .09 **
Triceps skin fold 
thickness *
168 ±  .69 85 ±  .45 **
Creatinine height index 112 ± 3 2 .2 80 ± 29 .8
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Figure 1.3 : Survival data from the NIH trial of COPD patients 
showing increased impact of low body weight on mortality in patients 
with less (lower panel) compared with patients with moderate (middle 
panel) and veiy severe (upper panel) airflow obstruction (Reproduced 
with permission).
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Figure 1.6 : Influence of concurrent illnesses on weight loss and lung function in 
COPD (after Bates; reproduced with permission from the original). Each 
intervening illness is associated witli decreased food intake and weight loss. Lower 
panel shows actual stepped decline in lung function of same subject compared to 
tlie predicted age related loss, which is linear.
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CHAPTER 2: Methods
2.1 Introduction
This chapter provides a description of the various 
methods of measurement used in the studies that comprise this 
thesis. Tire methods of measuring resting energy expenditure 
and the oxygen cost of breathing are described in greater 
detail tlian the standard and relatively well established 
techniques used to assess nutritional shitus and lung function.
2.2 Measurement of resting energy expenditure
;■2.2.1 Principles and practice
The energy spent by a person in the course of a 
day is the sum total of the basal metabolic rate or BMR, the
■ ■
energy cost of aiousal and physical activity and the
tliermogenic effect of food ( Figure 2.1, Ravussin and
■
Bogai'dus, 1986). Since ti’iie basal conditions ai'e difficult to 
define and seldom achieved, sleeping metabolic rate is 
accepted as a close approximation. For practical purposes 
resting energy expenditure (REE) is defined as the minimum 
rate of energy expended in an awake, relaxed, comfortable 
state in the supine or semi-supine posture after an overnight 
fast and is estimated to be about 8% greater than the sleeping 
metabolic rate. REE nomially constitutes 70- 80% of the total
i
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energy expenditure in sedentary persons. Of the REE, 90% is 
consumed by the various osmotic pumps which maintain a 
difference in electrolyte concentrations between intracellular
:s
and extra cellular' fluids and by the processes involved in the 
synthesis of vital proteins and macromolecules. At rest, less 
than 10% of the REE is required for breathing, cardiac 
contraction and the other mechanical processes that sustain 
Ufe.
Calorimetry is the science of energy measurement.
It is based on two fundamental principles. First, the law of 
tlrer-modynamics which states that energy can neither be 
created nor destroyed and therefore, by implication, the 
energy in a closed system is a constant. Second, the 
measurable form of energy expenditure is heat output. Almost 
200 years ago, Lavoisier, Priestly and Black demonstrated 
that combustion or energy generation was an oxygen 
consuming and heat generating process. Lavoisier and Laplace 
carried out experiments in which a guinea pig was placed in a 
small chamber covered with ice, and showed that the rate at 
which the ice melted over a ten hour period was related to the 
amount of CO2  produced by the animal (Guggenheim, 1981).
I
At the end of a centui'y which witnessed intense research 
activity in this field, Atwater and Rosa (Atwater and Benedict,
1899) succeeded in designing a chamber in which the heat 
produced by a human could be measui'ed with an accuracy of
 J
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0.1%. This technique whereby energy expenditure is estimated 
by the direct measurement of heat produced is called direct 
calorimetiy. In practice this is achieved by tlie measurement of 
heat changes within a chamber confining tlie subject or by 
using a heat exchanging body suit (Murgati'oyd et al, 1993). 
The methods employed by Atwater and co- workers to 
estimate energy expendituie and the measures of energy 
expenditure made by their equipment still remain the gold 
staiidai'd in tlie field of calorimeti'y. In addition to measuring
energy expenditure, the Atwater and Rosa chamber also 
enabled confirmation of two important hypotheses that form I
the basis of calorimetiy : (1) The total energy expenditure as 
measured by the heat produced was equal to the net energy 
from the food ingested (total chemical energy in food minus 
energy lost in faeces and urine), i.e. the fir st law of 
thermodynamics was true and (2) the total energy expenditure
was related quantitatively to the amount of oxygen consumed. 
It is the latter observation that foiTns the basis of indirect 
calorimetry.
2,2,2 Indirect Calorimetry
Indirect calorimetry is based on the principle 
that energy generation is an oxygen consuming phenomenon 
and therefore measurement of the amount of oxygen 
consumed provides a reliable indication of energy expended.
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Under conditions of equilibrium, estimates of energy 
expenditure obtained from measurement of gas exchange i.e., 
oxygen consumption and carbon dioxide production have 
been shown to compare veiy favourably with values obtained 
by the elaborate techniques of direct calorimetiy (Kinney, 
1988). This method of detennining energy expenditui'e by gas 
exchange measurements has achieved much popularity mainly 
due to the availability of a number of simple devices with 
inbuilt computerised data processing equipment (metabolic 
cai’ts) that measure oxygen consumption (V O2 ), carbon 
dioxide production (V CO2 ) and calculate energy expenditure 
from expired gas analysis (Kemper, 1989). There are a 
number of different types of such equipment, but in essence all 
of them measure the difference in oxygen and car bon dioxide 
content between inspired and expired gas, and where 
necessary, minute ventilation, to calculate V O2  and VCO2  
and hence REE (Figure 2.2). Expired gas is usually collected 
through a mouth piece after application of a nose clip 
(‘Closed system’ of indirect calorimetry). Expired gas may 
also be perforined on a sample of air dr awn from a chamber, 
usually a hood, which encloses the subject’s head or upper 
body (‘Open system of calorimetry).
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2.2,3. Factors influencing REE measurements ,
Measurements of REE need to be performed under 
strictly controlled conditions in order to be reliable. REE is 
usually measured after an overnight fast, in a relaxed, supine 
or semi-supine posture. The importance of maintaining a 
thermoneutral environment whilst calorimetry is being 
performed, particularly in the very young and the elderly, is 
well recognised. Buskirk et al (1960) provided evidence to 
show that previous nutrition, sleep patterns and body 
temperature are three of the other variables that influence 
REE. Methodological factors may also be of relevance, in 
particular', whether, during indirect calorimetr-y, expired gas is 
collected by a mouthpiece and nose clip system, face mask or 
a non-invasive ventilated hood (Kinney, 1988).
2.3. Prediction equations for REE used in the 
study
Although indirect calorimetr'y is a reliable method 
of estimating a person’s energy expenditure, the equipment 
and the expertise required to carry out the procedure are not 
readily available. In situations where calorimetr'y is not 
available, REE is usually calculated from one of many 
prediction equations that have been published (Harris and 
Benedict, 1919; Schofield, 1985; Quebbeman and Ausman,
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1982; Wilmore, 1977; Hansell et al, 1987). These equations 
were derived from calorimeti'y performed in normal subjects 
and aie used not only to predict REE when calorimeti'y is not 
available, but also as standai'ds against which measured REE 
values are compared. The most commonly used equations are:
(a) Harris- Benedict equations 119191: These are the most 
widely used and were derived from a population of 239 
healthy adults. There are sepai'ate equations for males and 
females; age, height and sex ar e the measured variables. The 
equations are as follows:
REE in kcalories /  24 hours
Male : 66.473 + 13.751 (weight in kg) + 5.03 (height in cm) - 
6.755 (age in years)
Female : 655.5095-t- 9.463 (weight) + 1.8496 (height) - 4.675 
(age)
(b) Schofield f19851 : These equations are increasingly used 
as they involve the measurement of only one variable, weight. 
The equations were derived from data pooled from 114 
separate studies involving over 7000 subjects of a wide range 
of body composition and ethnicity.
REE in MJ /  24 hours
Male : 31-60 yr. : 0.048 (weight in kg) + 3.653 ;
Over 60 yr.: 0.049 (weight) + 2.459;
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Female: 31-60 yr.: 0.034 (weight) + 3.538; 
Over 60 yr.: 0.038 (weight) +2.755;
HB equation (Goldstein et al 1987; Donahoe et al 1989; 
Wilson et al 1990; Schols et al 1991; Green and Muers,
1992). It is was felt that in order to conform to standard 
practice, REE obtained by the HB equation would be taken as 
the value against which comparison of measured values would 
be made. In patients with scoliosis and thoracoplasty in whom
:
i
(c) Ouebbeman - Hausmann (1982): Though not widely 
applicable to the general population, this equation has been 
used as a reference for a hospitalised or ill patient group
(Moore and Angelillo, 1988). The equations were derived 
from patients receiving parenteral nutrition for various
reasons.
REE inkcal/day
Males: 12.3 (weight in kg) + 754;
Females : 6.9 (weight) + 874
Based on body surface area (BSA):
Male : 789 (BSA) + 137
Female : 544 (BSA) + 414
Although it involves measurement of
.more variables (height and weight) than the Schofield
-equation (weight), the equation that has been used widely in 
studies of energy balance in patients with lung disease is the
i
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body height could not be considered a reliable indicator of 
body dimension, ann span was used in place of height in the 
HB equation (Harper et al, 1965). In these patients the 
Schofield equation was also applied and the results thus 
obtained are also quoted if  they were different from those 
obtained from the HB equation.
2.4 Indirect calorimetry in patients with lung 
disease - comparison of hood and mouthpiece 
plus noseclip systems
2.4.1 Introduction
The measurement of resting energy expenditure by
calorimetry is influenced by a number of biological and 
environmental factors (Buskh’k et al, 1960; vide supra). In the 
case of indirect calorimetry, in addition to the biological and 
environmental variables, certain methodological factors also 
come into play (Kinney, 1988). As discussed previously, 
indnect calorimetiy involves the collection for expired gases 
for analysis of oxygen and carbon dioxide content. Some 
investigators have shown that in normal individuals the 
method of expired gas collection, whether by relatively 
invasive mouth piece and nose clip system, face mask or by 
non-invasive systems like a ventilated canopy, has no bearing 
on REE measurements (Segal, 1987; Soares et al, 1989). 
However other workers have found that the use of invasive 4
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respii’atoiy appai'atus in the fonn of a mouth piece and nose 
clip increases the insphatoiy flow and tidal volume (Askanazi 
et al, 1980). If this were the case in subjects undergoing 
calorimetiy the use of such apparatus will influence the results 
of indirect calorimetry. Furthermore, as tlie ventilatory 
capacity of the population under investigation (patients with 
lung disease) is restricted it would also be possible tliat the 
documented effect of respiratory appar atus may have an even 
more pronounced influence on minute ventilation and 
therefore gas exchange measurements. It seemed appropriate, 
therefore, to assess the two systems, mouthpiece plus nose 
clip (“invasive”) and a ventilated hood (“non-invasive”), in the 
study population before adopting one of them as the standard
,for all the studies of energy expenditure. Hence a study 
comparing an invasive (mouth piece plus nose clip) and a non- 
invasive (ventilated canopy) system of indhect calorimetry 
was undertaken.
■I
I
2.4.2 Subjects and methods
Twelve patients with severe lung disease recruited 
from Respiratory outpatient clinics of the Glasgow Royal 
Infirmary and eight healthy were studied (Table 2.1). Six
I
patients suffered from COPD, four from COPD and
I
respiratory dysfunction due to previous chest wall surgery for 
tuberculosis (thoracoplasty). Two patients had respiratory
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failure secondary to scoliosis. The controls were healthy 
adults (current or past staff of the Respiratory Department 
and Department of Human Nutrition, Glasgow Royal 
Infirmary and their relatives) who were naive to the 
techniques employed in the study.
The study was approved by tlie local Ethics 
committee and all subjects gave informed consent.
Study protocol
The subjects were studied on two consecutive 
mornings in the fasting state. Indirect calorimetry was 
performed in a dedicated energy and exercise laboratory.
Patients who were being treated with inhaled beta agonist 
therapy were studied at least two hours after the last dose of 
the drug. After a 30 minute rest period during which a 
detailed explanation of the techniques was given, indirect 
calorimetry was performed first with a ventilated hood 
system. This was followed by a ten minute rest period after 
which REE was estimated by a mouth piece plus nose clip 
system. This order was followed in view of previous 
investigations in the field suggesting an ‘order effect’ in the 
measurements with the REE remining elevated for a Ï
considerably longer period of time following measurement
with a mouth piece and nose-clip system than with a non- 
invasive system (McAnena et al, 1986). Calorimetry by both
1
techniques was conducted at a room temperature of 20'C, 
with the subjects fully clothed in the semi-recumbent posture.
The same procedure was repeated on the second day. Lung 
function tests were carried out after calorimetry on the second 
day in all except one subject who was studied two days after 
calorimetry. At the end of the study, subjects were asked as to 
rate the two systems of calorimetry.
After the initial study, in order to assess the 
effect of respiratory apparatus on REE and RER, calorimetry 
was peiformed in eight subjects (controls) with the subjects 
breathing unimpeded within the hood and subsequently 
through a mouth piece plus nose clip system whilst within the 
hood. Experience in patients with lung disease indicated that 
such a procedure caused unacceptable respiratory distress and
''3i
this part of the study was not carried out in these patients.
Calorimetry
Hood system: (Figure 2.3): Indirect calorimetry with the hood
Îsystem was performed with the Deltatrac Metabolic Monitor 
™ (Datex instiumentarium corporation, Helsinki) (Appendix 
1). In this system the subject’s head is enclosed in a 
transparent plastic hood and ventilated with a constant flow of 
about 40 liters/min of room air. Infra-red and differential
...I '
paramagnetic sensors measure the differences in carbon
dioxide (CO2 ) and oxygen (O2 ) concentrations between
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inspired and expired air. Oxygen consumption (V O2 ), carbon 
dioxide production (V CO2 ) and respiratory exchange ratio 
(RER) were estimated every minute for a period of 20 
minutes. The data obtained in the first five minutes were 
discarded and data obtained in the last 15 minutes were used 
to estimate REE if there was less titan 5% minute to minute 
variation in the RER and V O2  (Appendix 2). REE was 
calculated using Weir's formula (Weir, 1949). Artifacts 
produced by coughing were automatically eliminated in the 
final calculations.
Arterial oxygen saturation was monitored 
(Radiometer Ltd., Copenhagen) during the study to ensure 
that patients did not desaturate whilst inside the hood. Gas 
calibration was performed before each measurement with a 
standard high purity gas luixture provided by the 
manufacturer. The system was checked by a methanol burning 
test every week during the study period and the average RER 
values for the last 15 minutes of a 30 minute methanol burning 
run were confumed to be within 0.64 and 0.69. Flow 
calibration was also peiformed by calculating the total amount 
of CO2  produced during the methanol burning test and the 
flow constant adjusted if the actual CO2  production differed 
from the expected values.
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The theoretical basis of the methodology and the 
data supporting the time course of the measurements ai'e 
given in Appendix 1.
Mouth piece system: (Figure 2.4) The mouth piece system 
(PK Morgan Ltd., Rainham, United Kingdom) involved 
subjects breathing through a low resistance, low dead space 
(150 ml) valve box. The valve box incorporates a turbine 
ventilometer in the expired limb for the measurement of 
ventilation. Expired gas was analysed for O2  and CO2
concentrations by para-magnetic and infra-red analysers 
. .respectively. V O2 , V CO2  and RER were averaged over a 
minute and measured for 15 minutes. Data obtained in the first 
five minutes were discarded and REE was calculated from the
■ ■„
remaining data. Gas analysers were calibrated as previously 
mentioned.
All subjects underwent lung function tests.
.Forced expiratory volume in the first second (FEV j)  and 
forced vital capacity (FVC) were measured using a whole 
body plethysmograph (PK Morgan Ltd) and expressed as 
percentage of predicted values (Grimby and Soderholm,
1963).
Statistics
Day to day and between method differences in REE 
were compared by paired ‘t ’ tests and Wilcoxon test, using a 
standard computer programme (MINITAB Release 9.2, State
I
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College, PA, USA). Mean difference between methods, 95% 
confidence intervals and ‘p ’ values were calculated. 
Significance was assessed at the 5% level. REE estimated by 
the hood and mouth piece techniques were also compared for 
limits of agreement by the method of Bland and Altman 
(1986). Pearson product moment correlation coefficient was 
used to assess correlation between variables.
2.4.3 Results 
Day to day variation
There was no significant day to day vaiiation in 
the REE measured by either method in patients and in 
controls (Figure 2.5). In controls mean difference between 
Day 2 and Day 1 with the hood was 11 kcal /  24h ( 95% 
Confidence Intervals: -22, 43; p = 0.4); mouth piece: -68 
kcal/ h; Cl : -188,13 kcal/ 24h; p = 0.16). In patients mean 
difference between Day 2 and- Day 1 with the hood technique 
was -11  kcal/ 24h (95% confidence intervals (Cl): - 69, 48 
kcal/ 24h; p =0.62); with the mouth piece system the value 
was: 23 kcal/ 24h (Cl : -76, 136; p = 0.64).
Between method variation
There was a significant difference between the 
methods in patients but not in controls (Figui'e 2.5). In 
controls the mean difference was 19 kcal/ 24h (95% Cl: - 65, 
92 kcal/ 24h; p = 0.57). In patients the mean difference in
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REE between the methods was 186 kcal/24h (95% Cl: 55, 
278 kca l/2 4 h ;p  = 0.01).
The mouth piece technique gave higher values 
than the hood system in 10 out of 12 patients and in 5 out of 8 
controls. As estimated by the method of Bland and Altman, 
the limits of agreement (mean difference ± 2 standard 
deviation) between the methods was much greater in patients 
than in controls (Figure 2.6); the range of difference between 
the two methods was also much higher in patients than in 
controls (-156 to + 467 kcal /  24h in patients vs - 126 to 120 
kcal/ 24h in controls).
Respiratory exchange ratio
In patients, but not in controls, respiratory 
exchange ratio (RER) was significantly higher when breathing 
tlu’ough the MP system (Figure 2.7). In patients, mean 
difference in RER between the method, RER in MP being 
higher, was 0.08 (Cl: 0.03, 0.13; p = 0.002). In controls the 
mean difference was 0.01 (Cl: -0.01, 0.03; p = 0.21).
Mouth piece in hood
There was some evidence (p <0.06) to suggest that 
REE and RER were higher when controls breathed through a 
mouth piece within the hood compared with breathing 
unimpeded in eight control subjects (Table 2.2). The mean 
difference in REE between breathing with the MP and
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breathing unimpeded was 71 kcal/ 24h (Cl : -10, 151 kJ/ 24h; 
p = 0.06) The difference in RER was 0.03 (Cl: 0.00, 0.07; p =
0.06).
There was a correlation between RER on the 
mouth piece and the difference between the two methods of 
estimating REE (r = 0.59; P < 0.05), but there was no 
correlation between lung function and the difference between 
the methods (r = -0.30). There was no correlation between 
the mean REE measured by the two methods and the 
difference between the methods.
Ten out of twelve patients expressed a preference 
for the hood method; one preferred the mouth piece system as 
she had felt claustrophobic in the hood; the remaining patient 
did not express a preference for either system. Four of the 
conti'ols preferred the hood, one the mouth piece; the other 
tliree did not express a preference for either system.
2.4.4 Discussion
The WHO Expert Consultation Report on
protein and energy requirements drew attention to the 
importance of measuring rather than predicting energy 
expenditure in the estimation of energy requirements of 
individuals (FAO/WHO/UNU Report, WHO technical report 
series, 724, 1985). Studies in healthy adults have shown that
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the methods employed to collect expired gas for measuring 
REE do not affect the results, and in routine circumstances
3■Ï
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use of a hood, mask or mouth piece systems for indirect Icalorimetry give similar results (Segal, 1987). However, 
others have suggested that a ventilated hood system is 
preferable to other systems of data collection as it is non- 
invasive and does not affect the subject’s breathing pattern
%
1 %
(Kinney, 1980).
M ost measurements of REE are brief and it is well
recognised that the RER measured in a non-steady ventilatory
state does not represent the respiratory quotient (RQ) of the
tissues (Kinney, 1980). Increased ventilation leads to a
washout of CO2  from the lungs and therefore an elevation in
the REE calculated from V CO2  values measured at the
mouth. In a study of healthy volunteers Askanazi et al (1980)
demonsti'ated that the use of respiratory apparatus (mouth
.piece plus nose clip) resulted in a stimulation of ventilation
and caused a significant increase in inspiratory flo w . It is
most likely that tliis effect, in the presence of compromised
■
lung function leads to more pronounced alterations in 
breathing pattern and work of breathing, resulting in elevated
RER and REE. This would account for the tendency of the 
mouth piece method to give higher values for REE (and RER) 
and the clearly wider difference in REE estimated by the hood 
and mouth piece methods in patients compared with healthy , r
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subjects. It is noteworthy that Segal’s study of healthy 
volunteers also documented an elevated, albeit statistically 
non-significant, RER in subjects using the mouth piece .
Lending support to the view that the mouth piece and nose 
clip system causes an increase in RER and REE is the 
observation that these measures are elevated when subjects 
were made to breathe through a mouthpiece and nose clip 
within the hood compared with breathing unhindered inside
Ithe hood (Table 2.2).
S'
The results of this study are of particular relevance 
to the investigation of the energy balance of patients with 
chronic lung disease. The apparently contradictory results of 
studies in this field may well be the result of methodological 
differences, as the study employing a non-invasive hood 
system found REE in malnourished COPD patients to be low 
(Ryan et al, 1993) whilst a study using a mouth piece system 
gave the opposite results (Donahoe et al, 1989). It is 
important that studies in the field adopt appropriate standard 
techniques and on the basis of the results of this study it seems 
appropriate that in patients with breathing difficulties more
reliable estimates of REE are obtained from a non-invasive 
ventilated hood system. The other advantage of the ventilated 
hood system in patients with lung disease is that it does not 
inhibit coughing, which is a common problem in this patient 
group. Not uncommonly measurements employing a mouth
£Ï
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piece and nose clip are interrupted by bouts of coughing, 
rendering the achievement of a steady state difficult.
It is however possible that in some patients (one 
out of twelve in this group) a feeling of claustrophobia may 
render the hood technique unattractive, and others have 
di'awn attention to the effect of interaction between subjects 
and the hood system in those unaccustomed to the apparatus 
(Soares et al, 1989). In such cases a mouth piece may be used 
to collect expired gases, bearing in mind that this apparatus 
may stimulate ventilation and thus cause a spurious elevation 
in REE. In these situations monitoring minute ventilation.
oxygen saturation and RER may enable detection of hyper 
.ventilation, alerting the investigator to the possibility of a 
methodological cause for an elevated REE.
2.4.5 Conclusion
In conclusion, this study has shown that the method 
of data collection has a greater influence on the results of 
indirect calorimetry in patients with breathing difficulties 
compared to healthy individuals. In these patients use of a 
mouth piece may stimulate ventilation and result in an over 
estimation of REE. Unless clausU'ophobic feelings preclude 
their use, non-invasive hood systems are preferable in this 
patient population. On the basis of tltis study all measurements
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of REE peiformed in the investigations of this tliesis were 
made with a ventilated hood system.
2.5 Oxygen cost of breathing
2,5.1 Principles and practice of measurement
The bulk of the work of breathing is directed at 
overcoming the resistance of the ah'ways, pulmonary tissue 
and the chest wall. In the healthy adult only about 20% of the 
total resistance is tissue resistance, the remaining 80% being 
airway resistance (Bartlett, 1979). Although it was 
acknowledged that the work of breathing was increased in 
patients suffering from clu'onic obsti'uctive lung disease, it was 
not until the late 1950s that consistent attempts were made to 
quantify this work in tenus of oxygen consumption. Partly, 
the interest in measurement of the oxygen cost of breathing 
(OCB) arose from attempts to verify the theoretically 
atti’active but unproved, and technically difficult to prove, 
hypothesis proposed by Otis (1954) that in patients with lung 
disease there was a point of "critical gain" at which the 
oxygen gain associated with increased ventilation was less 
than the oxygen cost of ventilation i.e. the oxygen 
consumption of the respiratory muscles and that this was the 
cause of effort limitation in these patients. The most 
commonly used method of estimating the oxygen cost of 
breathing was the added dead space technique originally
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described by Liljesti^and (1918). Other techniques have since 
been used by various investigators (Campbell and Westlake,
1959; Thung et al 1963). The principles underlying the 
various techniques are described below.
1. Closed ch'cuit. added dead space technique ILiljestrand.
1918) : The oxygen consumption (V 0%. R) and minute 
ventilation (Vg. R) at rest aie measured in the usual fashion.
After adequate data collection in a stable state a suitable dead 
space is added to the breathing circuit to cause an increase in 
ventilation and oxygen consumption. After a steady state has 
once again been reached the oxygen consumption (V O2  +) at 
the level of augmented ventilation (V g  +) is estimated. The 
oxygen cost of breathing is calculated as tlie increase in 
oxygen consumption between dead space and resting intervals 
relative to the increase in minute ventilation.
Oxygen cost of breathing (ml O2  /  litre
ventilation)
= ( V 0 2 + ) - ( V Q 2 ^
(Ve  +) - ( Vg-R)
2. Carbon dioxide induced ventilation (Levison and
f
Cherniack. 1968): Here ventilation is augmented, not by the
£
addition of a dead space but by increasing the fraction of I
fcarbon dioxide in the inspired air to 5%.
i-
1
:
3. Estimating OCB during mechanical ventilation IThung et 
al. 1963) :
In patients undergoing mechanical ventilation the work of 
Obreathing is peiformed by the ventilator. The difference 
between the oxygen consumption during spontaneous 
ventilation and that with the patient relaxed during artificial 
ventilation is taken as the oxygen cost of breathing. , |
2.5.2 Values for the oxygen cost of breathing
The actual values for the oxygen cost of 
breathing vary considerably depending on the technique and 
the levels of ventilation at which OCB was estimated. In 
general, in normal subjects, the oxygen cost of breathing i s l -  
2 ml Ü2 /  litie of ventilation over a minute ventilation range of 
6-15 litres/ min. Assuming a resting oxygen consumption of 
about 250 ml /  minute the oxygen cost of breathing is thus less 
than 5% of the total (l-2x 6 = 6-12 ml O2  /  min). However at
higher levels of ventilation, for example during exercise, the 
OCB increases such that at a minute ventilation of a greater 
than 50 1/min OCB is 8 - 10 ml /L, constituting a greater 
proportion of the total oxygen consumption. Table 2.3 
summarises the vaiious studies in the field of measurement of 
OCB.
i:■'4
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2.5.3 Description of technique used to measure OCB in 
study
OCB was measured by the method based on the 
technique described by Lijestrand (1918) and Cherniack 
(1958). Expired gas was collected via a mouthpiece attached 
to a low dead space valve and passed through to a metabolic 
measurement cait (Benchmark system, PK Morgan Ltd,
I
England). The cart measures ventilation by a flexible 
membrane flow meter. Oxygen and carbon dioxide tensions 
are measured with a zirconia crystal and a rapid infra-red 
analyser respectively. At the beginning and end of each 
measurement the gas analysers were calibrated using a high 
purity gas mixture (BOC Ltd). The flow meter was calibrated 
using a 5 litre syringe at vmious flow rates and accuracy of 
the flow measurements were confirmed to be within 2% over 
a wide range of flow rates. Resting V O 2  , V CO2  and minute 
ventilation (V g) were measured first for 15 minutes using the 
metabolic cart and the data obtained during a 5 minute period 
of stable ventilation (minute to minute variation in ventilation 
< 1 litre) was used in the calculations (Figure 2.8). Following 
this a 15 minute rest period of breathing without the 
mouthpiece was allowed. Then the subject was again
.attached to the mouthpiece, now with a dead space tubing 
added to the breathing circuit (Figure 2.9). The volume of the
I
„ __.'/r "
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dead space added was variable and aimed to increase the 
subject's minute ventilation by 5 to 10 litres. Once the subjects 
achieved a stable level of ventilation with the dead space, V 
0%, V CO2  and V g were estimated again over a stable 5 
minute period. Oxygen cost (in ml O2/  L ventilation) was 
defined as the ratio of the increase in the oxygen consumption 
between the dead space and resting ventilation relative to the 
increase in minute ventilation.
beam balance (Weylux Model 424, England). Subjects were 
weighed standing baiefoot in light indoor clothing. In studies 
involving serial measurements, weighing was done at the same 
time of tlie day. The beam balance was calibrated at monthly 
intervals with known weights over the measiu’ement range (30
I
a
2.6 Measures of nutritional status
The nutritional measures that were made during
,the study were: body weight, skin-fold thickness at four 
standard sites and mid-upper arm circumference. Mid-arm
-
muscle ch’cumference was calculated as noted below. Body 
height and ann span were also measured as indices of stature.
2.6.1 Body weight
.
Body weight was measured to the neatest 0.1 kg by a
■
fir3
Î
t
- 100 kg).
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Triceps skin fold thickness (TSF): With the elbow flexed to a 
right angle, the mid-point between the acromion and the
2.6.2 Body height and arm span
Body height was measured to the neatest centimette 
using a stadiometer attached to the weighing scales, with the 
subjects head in the Frankfurt plane (lower border of the 
orbital margin and upper border of the external auditory 
meatus in the same horizontal line).
Arm span was measured the distance between the tips 
of the middle fingers with the arms abducted to right angles. 
In patients with musculoskeletal deformities ann span was 
used as a measure of body dimension in lieu of height (Harper 
et al 1965).
2.6.3 Skin fold thickness
Skin fold thickness was measured at four standard sites .3'-%;(triceps, biceps, subscapular and suprailiac) with the Holtain 
calipers (Dyfed, United Kingdom) (Durnin and Womersley, 
1974). The calipers were calibrated at regular- intervals using a 
calibration block. In patients with chest wall deformities 
subscapular and suprailiac skinfolds were grossly distorted 
and therefore these were not measured. :
-i
.
olecranon processes was mat'ked and the skin-fold at this 
point picked between the thumb and forefinger of the left 
hand (Figure 2.10). The calipers were applied and the reading 
on the dial taken as soon as the phase of rapid compression
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was over. Three measurements were made and averaged. If 
the first three readings were not within 2 mm of each other, 
the measurements were repeated until tiuee consecutive 
readings agreed to 2 mm.
Biceps skinfold: This was measured as the tliickness of the 
vertical fold on the front of the left aim, directly above the
axillai'y line immediately superior to the iliac crest (Lohman et 
al, 1968).
Mid upper arm circumference (MAC) and Mid-ann muscle 
circumference IMAMC)
Mid upper arm circumference was measured with a steel tape
i
cubital fossa, at the same level as the triceps skin fold (Weiner 
and Lourie, 1969).
Subscapular skinfold: Measured below and lateral to the angle 
of the left shoulder blade, with the shoulder and arm relaxed. 
The skin fold was raised at the same angle as tlie inner border 
of the scapula (medially upward and laterally downward)
Ï
(Lohman et al, 1968).
Suprailiac skinfold: This skinfold was measured in the mid-
:l
(Holtain Ltd, Dyfed), at the same level as the triceps and 
biceps skinfolds (Figure 2.11).
Mid arm muscle circumference (MAMC) was calculated by 
the formula :
MAMC (in cm) = MAC (in cm) - 7C TSF.
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2.6.4 Body composition
A number of techniques are available for the
determination of body composition, most based on the two 
compaitment model which considers the body to be made of 
two chemically distinct compartments - fat and fat-free, the 
latter also referred to as lean body mass (Lukaski, 1986). The 
method that was employed in a study in this investigation was 
total body potassium measurement. This technique is based on 
the principle that potassium (K +) is an intracellular cation 
that is not present in fat and that all the measurable K+ 
content of the body comes from the fat free mass (Forbes et 
al, 1961). Total body potassium (TBK; the isotope K+ 40) is 
measured by a specially constructed counter; the potassium 
content of fat-free mass being known from factors derived 
from cadaver analysis (2.46 g/ kg FFM for men and 2,28 g/ kg 
FFM for women, Behnke, 1974), FFM is derived from the 
measured TBK value.
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2.7 Pulmonary function tests
2.7.1 Lung volumes and spirometry
Vital capacity (VC) and forced expiratory volume in 
the first second (FEV%) were measured as indices of 
pulmonary function. The tests were peiformed using a body 
plethysmograph system (PK Morgan Ltd, Kent). Procedures 
were performed in accordance with fomaal guidelines wliich 
have since been recommended by the British Thoracic Society 
and the Association of Respiratory Technicians and 
physiologists (Guidelines for the measurement of respiratory 
function, 1994). Results of at least three technically 
satisfactory manoeuvres were inspected and the best value 
was chosen for analysis. Measured pulmonary function was 
compared with reference ranges and expressed as a 
percentage of predicted values (Grimby and Soderholm,
1963).
2.7.2 Exercise capacity
Bicycle ergometiy: Symptom limited exercise tests were 
carried out initially using an electrically braked bicycle 
ergometer (Siemens Ltd) with the patient breathing through a 
low dead space low resistance valvebox. The valve box 
incorporated a turbine ventilometer on the inspired limb for 
the measurement of ventilation. Expired gas was analysed for 
oxygen (O2 ) and carbon dioxide (CO2 ) by an infra-red 
spectrometer and para magnetic analyser respectively 
(P.K.Morgan Ltd, England). After a 2 minute rest period
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while seated on the bicycle the patients were instructed to 
cycle with no additional load for 2 minutes. Thereafter the 
load was increased by 25 watts every 2 minutes until 
symptoms limited exercise. Two trial tests were performed on 
separate occasions before the first exercise test to familiarise 
the patients with the equipment and avoid confounding of the 
results by a training effect. The maximum value for oxygen 
consumption attained (V 0% max) was taken as an indicator 
of peak exercise capacity.
Six minute walking test: After the initial investigation using 
bicycle ergometry was completed, some of the patients taking 
part in the investigations noted that, despite familiarisation 
with bicycle ergometry, a measure of exercise capacity which 
was more in keeping with activities of day to day living would 
be preferable and therefore, for the subsequent study of 
nutritional supplementation and Clenbuterol a six-minute 
walking test was used. In this test subjects were asked to walk 
as far as they could in six minutes, with a standard 
encouragement (Butland et al, 1982). Familiaiisation with the 
test was achieved by two practice tests (Guyatt et al, 1984).
2.7.3 Respiratory muscle strength
1
■5
Maximal insph'atory and expiratory pressures (P I  and 
P E max) were measured at the mouth indicators of
respiratory muscle strength. The apparatus was based on that 
described by Black and Hyatt (1969). P I  max was measured 
from functional residual capacity (FRC) and PE max from 
total lung capacity (TEC), in accordance with standard
96
practice. The highest of three technically satisfactory
measurements was taken as the value for analysis in each case.
2.8 Peripheral muscle strength assessment
Peripheral muscle strength was measured by hand
grip dynamometry, using commercially available equipment 
(Grip dynamometer. Model 1201; Takei & Company, Tokyo, 
Japan). Subjects were instructed on the use of the equipment 
and the best of three grips with the dominant hand was taken 
as an indicator of peripheral muscle strength (Values 
expressed in kg-W).
1
...ÿ.
I
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Controls (n = 8) Patients (n = 12)
Age (yr.) 53 ± 14.5 61.9 ± 10 .4
Sex 4 male; 4 female 6 male; 6 female
Weight (kgs) 60.3 ± 6.2 59.8 ± 7 .1
Height (cms) 163.7 ± 7 .9 162.7 ±11.3
FEV 1 ( % predicted) 95.6 + 9.1 34.9 ± 9 .6
1
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Table 2.1
Characteristics of study population for the study comparing 
hood and mouthpiece systems of indirect calorimetry . 
Values as Mean ± SD.
Key to abbreviation : FEV 1 - Forced expiratory volume in 
first second.
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2000 p = 0.57
■  DAY1 
DAY 2
Hood Mouth P iece
CONTROLS (n =8)
REE
All values in kcal
2000 p = 0.01
p = 0.62 p = 0.64 ■  DAY1 
DAY 2
Hood Mouth P iece
PATIENTS (n=12)
Figure 2.5; REE in patients and controls estimated by the
two systems on two days. Note the absence of day to day 
variation in both systems but a significant difference between 
the systems in patients but not controls.
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F ig u re  2 .6 : Bland and Altman plots showing a greater mean 
difference between the methods in patients but not in controls 
(all values in kcal). Tlie limits of agreement between the 
methods for patients are 606 and -233 kcal/24h, whilst for 
controls it is only 19 and -158 kcal/24h.
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Figures 2.8 and 2.9 : Measurement of oxygen cost of 
breathing. Upper figure shows normal breathing; lower figure 
shows breathing through added dead space.
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F ig u res  2 .1 0  and  2 .11 : Measurement of mid-arm 
circumference and triceps skin fold thickness.
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CHAPTER 3: Resting energy expenditure 
and lung function in patients with chest 
wall disease
3.1 Introduction
One of the theories put forward to explain the 
weight loss in patients with emphysematous COPD is that 
airflow obstruction results in an increase in the work of 
breathing, which causes an elevation of REE and this, in the 
face of normal or reduced calorific intake results in net 
negative energy balance and weight loss (Donahoe et al,
1989) (Figure 1.5). A study of patients with respiratory 
insufficiency and (by implication) increased work of breathing 
due to interstitial lung disease, revealed that these patients too 
had higher than predicted resting metabolic rates (Fitting et al,
1990), lending support to the view that the increased work of 
breathing causes of an elevated REE in patients with 
respiratory impairment. However, more recent studies have 
shown tliat this is not always the case and that malnourished 
COPD patients and other patients with chronic airflow 
obstruction, including asthmatics, are not always hyper 
metabolic (Green and Muers, 1992; Ryan et al, 1993).
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Scoliosis is a condition characterised by an abnormal 
curvature of the spine and an associated defonnity of the 
thoracic cage (Figure 3.1). Respiratory function abnormalities 
are quite common in patients with scoliosis (Bergofsky,
1979), and cardiorespiratory failure is a well recognised 
complication (Branthwaite, 1986). The respiratory 
dysfunction in scoliosis results from a number of distinct but 
related mechanisms (Kafer, 1975). Most important amongst 
these are (a) the abnonmal elastic and mechanical properties of 
the respiratory system consequent upon the vertebral and rib 
cage deformity and (b) impaired respiratoiy muscle function 
(Lisboa et al, 1985). It is well accepted that tlie abnormal 
thoracic cage architecture imposes a considerably greater load 
than normal on the chest bellows mechanism (Figure 3.2), 
with the result that the work of breathing is considerably 
increased (Bergofsky, 1979; Jones, 1985). A similar problem 
exists in patients with thoracoplasty, a condition in which ribs 
which form a part of the bony thoracic cage are removed 
surgically, usually as treatment for tuberculosis (Figure 3.3).
Given that it has been suggested that severe respiratory 
dysfunction and by implication, increased work of breathing, 
increases resting energy expenditure in patients with lung 
disease, and that patients with chest wall deformities suffer 
from an increase in the work of breathing, it was felt that
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studying their lung function and resting energy expenditure 
(REE) would provide a useful insight into the relation 
between the work of breathing and REE in patients with 
chronic respiratory insufficiency in general. In tlie case of 
patients with COPD and pulmonary fibrosis, the two groups 
with lung disease in whom REE has been reported to be 
elevated it is possible that in addition to the increased work of 
breathing coexistent subclinical inflammatory phenomena 
(infection in COPD, alveolitis in pulmonary fibrosis) may have 
influenced resting energy expenditure. In comparison in 
patients with chest wall deformities tire only known major 
abnormality that could have a bearing on resting energy 
expenditure is the work of breathing. Hence in order to study 
more clearly the impact of the work of breathing on resting 
energy expenditure, a study investigating the resting energy 
expenditure of patients with chest wall deformities was 
conducted.
3.2 Subjects and methods
Twenty patients with chest wall disease and ten age 
and sex matched controls were studied (Table 3.1). All the 
patients were recruited from a specialist clinic to which they 
had been referred for assessment for domiciliary ventilation. 
All the patients were stable at the time of investigation with
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3.2.1 Indirect calorimetry
REE was estimated by indirect calorimetry using a
ventilated hood system as described in detail in the previous
no evidence of intercuiTent respiratory tract infection. Thyroid 
function tests were not performed but there were no 
symptoms or signs in any of the patients to suggest thyroid 
disease. None of the patients suffered from an active 
gastrointestinal disorder or cancer. The controls were healthy 
volunteers who were employees or relatives of employees of 
the Glasgow Royal Infirmary.
The study was approved by the local Ethics 
committee and all subjects gave their infomned consent.
chapter.
Oxygen consumption (V O2 ), carbon dioxide 
.production (V CO2 ) and respiratory exchange ratio (RER)
were estimated every minute for a period of 20 minutes. The 
data obtained in the first five minutes were discarded and data 
obtained in the last 15 minutes were used to estimate REE if 
there was less than 5% m inute to minute variation in the RER 
and V O2 . REE was calculated using Weir's formula (Weir, 
1941). Arterial oxygen saturation was monitored by a pulse 
oximeter (Radiometer Ltd., Copenhagen) during the study to 
ensure that patients did not desaturate whilst inside the hood.
3.2.3 Anthropometry
Body weight was measured to the nearest 0.1 kg by 
a beam scale (Weylux Model 424, England) with the subjects 
standing barefoot and expressed as a percentage of ideal body
.Gas calibration was performed before each measurement with
a standard high purity gas mixture as described earlier. i
The values for REE obtained by indirect 
calorimetry were compared with values predicted by the 
Harris-Benedict equation, using height, weight and sex (HaiTis 
and Benedict, 1919) and the Schofield equation (1985). As 
height is an unreliable anthropometric measure in patients with 
chest wall deformities, arm span was used instead of height in 
the HB equation and other calculations (Harper et al, 1965).
As confirmation, the Schofield equation, which involves the 
use of weight as the only measured variable and does not 
include height, was also used to predict REE.
3.2.2 Lung function
Vital capacity and forced expiratory volume in first 
second were measured using a body plethysmograph system 
(PK Morgan Ltd, Rainham, England) and expressed as a 
percentage of predicted values (Grimby and Soderheim, 
1963).
Î
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weight (IBW) (Metropolitan Life Insurance Company Weight 
Standards for men and women. New York: Metropolitan Life, 
1983). Height and arm span (distance between the tips of 
middle fingers of the two hands with the arms abducted to 
right angles) were measured to the nearest centimetre. Triceps 
skin fold thickness (TSF) was measured to the nearest 0.2 mm 
by skin fold calipers (Holtain Ltd, Dyfed, United Kingdom) 
using the standard technique (Durnin and Womersley, 1976). 
M id-arm circumference was measured and m id-arm muscle 
circumference was calculated as previously discussed.
3.2.4 Statistical analysis
REE of patients and controls, measured and
predicted REE were compared by paired ‘t ’ tests. Stepwise 
regression analysis was performed with measured REE as the 
dependent variable, weight, MAMC and percentage predicted 
VC as explanatory variables (MINTAB, Clecom Ltd, 
Birmingham, England). Correlation between % REE and % 
VC, between % IBW and % VC were also calculated by
f
Pearson product moment correlation.
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3.3 Results
3.3.1 Anthropometry and pulmonary function tests
Results aie summarised in Table 3.2. TSF and 
MAMC data were not available in two patients. There was no 
significant difference in the mean body weight of patients and 
controls, although seven subjects in the patient group were 
less than 90% ideal body weight whilst only two in the control 
group were so. Significant differences were evident in MAMC 
and indices of pulmonary function.
3.3.2 Indirect calorimetry
There was no significant difference between 
measured REE and REE predicted by the HB or Schofield 
equation (Figure 3.4). There was also no difference in the 
measured REE of patients and controls (Figure 3.5). Five 
patients had REE greater than 110% predicted by the HB 
equation (four if the Schofield equation was used) while only 
one control had an REE of greater than 110% predicted. The 
patients with an REE of greater than 110% predicted were 
not exclusively on any drug (two on theophylline, two on 
protriptyline)
a
M5
3.3.3 Relation between REE and other variables
On step wise regression analysis 71.8% of the variation 
in REE was explained by body weight, 74.4% by body weight 
plus MAMC, 78.8% by weight, MAMC and % predicted VC. 
There was no relation between % VC and indices of 
nutritional status (% IBW or MAMC) (Figure 3.6). There was
3.7).
The expression of REE in tenns of units per kilogram 
body weight did not alter the results.
also no relation between % predicted REE and % VC (Figiure
3.4 Discussion
Malnourished patients with COPD have been shown
to be hyper metabolic ( REE >110%  predicted) and this state
of hypermetabolism, in the face of normal or reduced food
intake, is believed to be the cause of weight loss in these
patients. One study which measured the oxygen cost of
breathing and energy expenditure of emphysematous patients
showed that malnourished patients were characterised by an
elevated oxygen cost of breathing and REE, suggesting that
the increased work of breathing m ight account for the hyper
metabolic state (Donahoe, 1989). A study of patients with 
.interstitial lung disease appeared to confirm this view, with
,
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indirect calorimetry in a group of twelve patients with ILD of 
different aetiologies showing REE to be elevated by around 
18% - 21% above predicted values (Fitting et al, 1990). The 
latter study also revealed a relationship between % IBW of 
patients and % predicted VC, raising the possibility that in 
patients witli lung disease there was direct relation between
body weight and lung function. However more recent studies I
have shown that malnourished patients with COPD (Ryan,
1993) and indeed other patients with increased work of
breathing due to asthma (Green and Muers, 1992) are not 
always hyper metabolic, and that the work of breathing does
I
not always elevate REE. The new work of this thesis in 
hitherto unstudied patients with respiratory impairment due to 
chest wall disease supports the latter view. Of the twenty 
patients with chest wall deformity and respiratory distress 
severe enough to warrant refeiTal for consideration of 
domiciliary ventilation, only five patients had an REE of 
greater than 110% predicted. Also these hyper metabolic 
patients were not necessarily the ones with most severe 
respiratory impairment or decreased body weight, as 
demonstrated by the poor correlation between %IBW and 
%VC and between % predicted REE and %VC.
The significant difference in MAMC between 
patients and the control group in the presence of comparable
i
f-
I
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decreased MAMC is the relative wasting of the upper arm
>■:îv
IBW merits comment. One possible explanation is that this
freflects a depletion of muscle mass, total body weight being
'
preserved due to fluid retention. However none of the patients 
was oedematous at the time of investigation and it is therefore 
unlikely that fluid retention is the cause of normal body 
weights. It seems likely that the nonnal %IBW in patients
represents normal body cell mass and the reason for the
musculature which is seen in most patients with 
musculoskeletal defomiities. Unfortunately reliable data on
the total lean body mass of the patients with chest wall 
deformities is not available. Skin fold anthropometry was 
clearly inappropriate in patients with deformed thoracic cages 
due to anatomical abnonnalities of the subscapular and 
suprailiac skin folds. Thoracic cage deformities also prevented 
body composition estimation by whole body potassium
counting as patients were unable to pass thr ough a counting 
chamber of narrow dimensions in the supine posture. Under 
water weighing was available as a method of estimating body 
composition (Lukaski, 1987) but most patients were unwilling 
to undergo the investigation. The view that the decreased 
MAMC and normal %IBW in patients represents a relative 
wasting of upper limb musculature and not total lean body 
mass is thus conjectural.
i
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3.5 Conclusion
In conclusion, REE is not elevated in patients 
with severe respiratory impairment due to chest wall disease.
There is no relation between lung function, resting energy 
expenditure and nutritional status in these patients. These 
finding raise the possibility that the work of breathing may not IIbe a major determ inant of energy imbalance and poor 
nutritional status in patients with chronic lung disease.
I
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Figiire 3.1: Chest radiograph of patient with chest wall 
disease due to congenital scoliosis, detailing the severe 
mechanical defonnity of the thoracic cage.
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A)
Pressure(cmHjO)
Min Vol. 0
Volume units
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20=
Pressure
4 0  ( c m H g O )
0  
Volume units
F ig u re  3 .2  : Pressure volume relationship in a normal 
individual and a patient witli chest wall disease. The curve is 
much flatter in chest wall disease indicating that to effect 
similai' changes in lung volume, the patient witli chest wall 
disease has to generate greater pressures, resulting in an 
increase in the work of breatliing.
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F igure  3 .3 : Chest radiograph of patient with a thoracoplasty.
Note absence of ribs and flattening of the thoracic cage on the 
left (apex).
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F ig u re  3.4: REE of patients compared with values predicted
by Harris-Benedict and Schofield equations.
(Values as mean (SE)).
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Figure 3.5 REE in patients with chest wall disease and in 
controls (Values given in absolute terms; scatter and results 
essentially unchanged if values are expressed as % predicted).
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F ig u re  3 .6 : Regression analysis between indices of 
nutritional status and indices of lung function.
Abbreviations: VC - Vital capacity; MAMC - Mid-arm muscle 
circumference; IBW- Ideal body weight.
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4.1 Introduction
pai'ameters were measured in patients with respiratory 
impairment due COPD and in some of the patients with 
scoliosis and thoracoplasty who participated in the previous 
study .
CHAPTER 4; Relation between REE, 
oxygen cost of breathing and nutritional 
status in patient groups with different 
types of chronic lung disease (emphysema, 
scoliosis and thoracoplasty)
The study that constituted the previous 
chapter showed that REE was not significantly elevated in
patients who are known to have an increased work of 
breathing due to chest wall disease. It was concluded that 
respiratory impainrient presumed to result in an increase in the 
work of breathing is, in itself, probably not enough to produce 
a significant elevation in REE. However, no measurement, 
direct or indirect, was made of the actual work of breathing.
In order to detennine whether an increased work or oxygen 
cost of breathing (OCB) is associated with an elevated REE 
and malnutrition and to explore further the relation between 
REE, OCB, lung function and nutritional status, these
I
I
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4.2 Patients and methods
4.2.1 Patient characteristics
Six COPD (3M 3F; mean age 67.0 yr. (SD 3.0)), six 
scoliosis (3M 3F; 51.0 yr. (7,2)), six thoracoplasty (2M 4F; 
61.7 yr. (5.7)) patients were studied. All the patients were in a 
clinically stable state, free from overt oedema and signs of 
respiratory ti'act infection. All the COPD patients and five of 
the thoracoplasty patients were on inhaled beta-agonists.
There had been no changes in the drug therapy of any of the 
patients in the three months prior to the study. All patients 
were current non-smokers; all the COPD patients, four 
thoracoplasty patients and two scoliotic patients were ex­
smokers. Six non-smoking healthy volunteers (2M 4F; 45,5 
yr. (9.9)) were also studied in order to assess the reliability of 
the various techniques used in the study.
4.2.2 Nutritional measures, calorimetry and lung function
These were made according to techniques previously 
described in detail (Chapter 2). TSF and MAMC were 
measured and also compared with normal values and 
expressed as percentage predicted (Bishop et al, 1981).
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4.2.3 Oxygen cost of breathing
OCB was measured by the method described in 
detail in Chapter 2. (Section 2.4; Figures 2.8 and 2.9). At the 
beginning and end of each measurement tlie gas analysers 
were calibrated using a high purity gas mixture (BOC Ltd). 
Accuracy of the flow measurements were confinned to be 
within 2% over a range of flow rates. The coefficient of 
variation for V 0% measurements with added dead space, 
based on a study of ten patients on separate occasions, was 
between 6 - 11%. It was felt that given the relative 
unpredictability of a patient's response to dead space 
breathing this was an acceptable level of variability and could 
not be improved upon any further by refinements of this 
particular technique.
4.2.4 Statistical methods
Data was analysed using the MINITAB statistical 
programme (Clecom, Bkmingham, UK). Compaiison between 
the patient groups was by analysis of variance. C ondadon 
between variables was determined in each group by Pearson 
product moment correlation coefficient. Linear regression 
equations were developed using stepwise regression analysis. 
REE was used as the dependent, response valuable, body
131
weight, lung function, and OCB as independent, explanatory 
variables. Significance was assessed at the 5% level.
The study was approved by the local Ethics 
committee and the patients gave their informed consent to the 
investigations.
4.3 Results
4.3.1 Anthropometric measures and pulmonary function
(Table 4.1)
All patients in the COPD group, 4 in the scoliosis 
and 3 in the thoracoplasty group were less than 90% ideal 
body weight. Comparison between the three patient groups by 
analysis of vaiiance showed no significant difference in any of 
the measures except vital capacity.
4.3.2 Resting energy expenditure (Figure 4.1)
REE was greater than 10% of predicted values (Harris-
Benedict equation) in 1 COPD , 2 scoliotic and 2 
thoracoplasty patients. All conti’ols had REE within 10% of 
the predicted values. There was no significant difference in the 
fasting RQ of the various gi'oups. The hyper metabolic 
patients were not different either in terms of drug therapy or 
smoking status from the patients whose REE was within the 
nonnal range.
3
I;:
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Thoracoplasty : - 0.62; Scoliotics: 0.41; controls : 0.56).
4.3.3 Oxygen cost of breathing (Table 4.2)
OCB was 3 or 4 times higher in patient groups 
compared with contiols. Analysis of variance showed no 
significant difference between patient groups.
4.3.4 Oxygen cost and lung function (Figure 4,2 and 4.3) 
There was a negative relation between OCB and FEV 1 
and between OCB and VC in all patient gioups. The 
correlation was significant at the 5% level in the COPD
group.
Oxygen cost and REE : There was no relation between OCB 
and REE (r values for OCB vs REE : COPD = 0.15; 1
There was no correlation between REE and
;|
indicators of nutritional status (T S F  or MAMC) in any of the 
groups.
On multiple regression body weight alone accounted 
for over 80% ( r^ =83.6) of the variation in measured REE .
1
■
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4.4. Discussion
The relation between REE, lung function, oxygen 
cost of breathing and malnutrition in patients with lung 
disease, particularly COPD and cystic fibrosis, has been the 
focus of much attention in recent year s (Donahoe et al, 1989; 
Schols et al, 1991; Naon et al, 1993). While some studies 
have shown that both well nourished (Lanigan et al, 1990) 
and malnourished patients are hyper metabolic (Goldstein et 
al, 1987), others have concluded that hyper metabolism is not 
a universal feature of these patients (Green and Muers, 1992; 
Ryan et al, 1993). In the present study of the thesis only five 
of eighteen patients with different types of respiratory 
impainnent (COPD, chest wall disease) exhibited an elevated 
REE. Oxygen cost of breathing was elevated in line with 
deteriorating lung function but was not always associated with 
an elevation in REE . Moreover, there was no consistent 
relationship between REE, OCB and indicators of nutritional 
status. This study thus adds support to the view that the 
increased work of breathing is not always accompanied by an 
elevated REE and that a high OCB per se is unlikely to 
account for the poor nutritional status of patients with lung 
disease.
One possible reason for the results of this study 
differing from that of Goldstein (1987) and Donahoe (1989) is
- ■■■/.;
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methodological. Firstly, this study used a non invasive system 
to measure REE in order to circumvent the effect of 
respiratory apparatus on the breathing pattern (Askanazi et al,
1980). As already demonstrated in the study described in 
detail in Chapter 2, in patients with severe respiratory 
impairment there is a significant difference in the REE 
estimated by die ventilated canopy and mouthpiece plus nose 
clip systems, with the latter consistently tending to 
overestimate the R E E . Secondly patients were all studied in
1979), there are no data in the literature regarding their actual
■,:.ïi
,r-
the fasting state early in the morning in this study, unlike those 
of other workers whose patients were studied at various times 
of the day whilst on an inti avenous infusion of nutrients 
(Goldstein et al, 1987).
: |Although it is known that the work of breathing is 
increased in patients with chest wall disease (Bergofsky,
oxygen cost of breathing. Since the values for OCB in patients 
with COPD obtained in this study (6.5 (1.3) ml O2 /  L) match 
well with studies by Cherniack (5.96 ml O2 /  L) and Levinson 
and Cherniack (6.3 ml O2 /  L), it would appear that the 
methods applied in this study were reliable and compaie with 
those of previous investigators. This study of the OCB of 
patients with chest wall disease and COPD leads to the 
conclusion that in both these patient groups OCB is elevated 
in line with their respiratory dysfunction. It must however be
%
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noted that the cause for an increase in the work of breathing 
in either group is veiy different: in patients with COPD it is 
due to an increase in airways resistance while that in patients 
with chest wall deformities it essentially the result of 
alterations in chest wall compliance characteristics 
(Cherniack, 1959; Kafer, 1975).
Whilst the techniques and methodology seem 
reliable, as demonstrated by the results of studies on controls,
this study as a whole suffers from some limitations. Like other 
studies in this field (Goldstein et al ,1987; Donahoe et al,
1989; Ryan et al, 1993), this study is small and this obviously 
limits its power. For example, whilst the correlation between 
OCB and lung function for the study population as a whole 
(n=24) is stiikingly significant (OCB vs FEV 1, r = 0.87),
because of the small numbers in each group (n=6), 
correlations in each group, while showing a consistent 
negative trend, do not reach significance except in the COPD 
group. Also, in this group of eighteen severely disabled 
patients only five were found to be hypermetabolic. A greater 
number of such patients would have allowed a valuable Î
comparison of patients with normal and elevated resting 
energy expenditure, inespective of underlying disease. It is 
also arguable as to whether the cost of augmenting ventilation 
(i.e., ventilation at a higher minute ventilation) can be taken to
136
be the cost of resting ventilation, especially in patients who 
may find it difficult to augment their ventilation. It is certainly 
possible that the oxygen cost of resting ventilation is not 
particularly different in patient groups and that the OCB rises 
at different rates with increasing ventilation. Thus the 
differences in the oxygen cost of augmenting ventilation need 
not represent a difference in the oxygen cost of resting
.
ventilation. Similar criticism of methodology would, however 
apply to the other studies in this field.
The uni'eliability of various antliropometric 
measures in patients with chest wall deformities (scoliosis and 
thoracoplasty) was discussed in the previous chapter and 
merits re-emphasise. The Harris-Benedict equation uses a 
subject's age, sex, height and weight to calculate REE. In 
patients with skeletal deformities height could not be used as a 
measure of body dimension and armspan was used instead.
Using the Schofield equation, which is based on weight, age
■
and sex, did not alter tlie results. The presence of thoracic 
cage deformities rendered measurement of subscapular and 
suprailiac skinfold thickness unreliable, making 
anthropometric estimation of body composition difficult. As 
noted in the previous chapter it was proposed that body 
composition be measured by under water weighing, but this 
technique did not find favour with the patients and was not 
pursued. Therefore potentially useful data on the body
137 ï
.composition of the various patient groups and its relation to 
their REE are not available. It is however worth emphasising 
that this does not in any way deti’act from the conclusions of 
the study, as normalising REE values for body composition 
w ithout reference to a larger population is not, in itself, 
particularly satisfactory (Ravussin and Bogardus, 1989); also, 
as has been pointed out, normalisation to lean body mass, 
paiticulatiy in malnourished, weight losing individuals is a far 
from satisfactory method of standardising REE (Shetty,
1993).
4.5 Conclusions
• S.:
.5
In conclusion, this study has shown that in clinically 
stable patients with respiratory disease the increased oxygen 
cost of breathing is inversely related to lung function. There is 
no consistent relation between oxygen cost of breathing, 
resting energy expenditure and nutritional status in these 
patients. It is unlikely that the increased oxygen cost of 
breathing is the sole or major cause of negative energy 
balance and malnutrition in patients with lung disease.
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CHAPTER 5: Pharmacological influences on 
energy balance in patients with COPD: 
thermogenic response to salbutamol
5.1 Introduction
Adrenergic di'ugs increase energy expenditure in a dose related 
manner (Fellows et al, 1985). It has recently been shown in healthy 
adults that even therapeutic doses of inhaled (3 agonists result in a 
considerable increase (in the order of 1 0 -2 0 %) in oxygen consumption 
and carbon dioxide production (Amoroso et al, 1993). Whilst the exact 
mechanisms by which tliis thermogenic effect is mediated are still 
unclear’, it is possible that this effect may have a bearing on the energy 
balance of COPD patients with chronic use leading to a state of hyper 
metabolism, which, in the face of normal or reduced intake, may 
contribute to negative energy balance. Studies in healthy volunteers have 
shown that this thermogenic effect, like other systemic, non- 
bronchodilator effects of (3 agonists, is abolished by regular use of the 
ding (Wilson et al, 1993). However it is not known whether this applies 
in a clinical situation in patients with COPD who have been long term 
users of the drug. It is also possible that while beta agonists could 
increase thennogenesis in patients witli COPD, they might also decrease 
energy expenditure by their salutary effect on the energy cost of 
breathing by relieving airflow obstruction. In order to clarify tire net
144
effect of therapeutic doses of inhaled beta agonists on the energy balance 
of patients with COPD, a study of the thermogenic response to inhaled 
salbutamol was undertaken in these patients.
5.2 Methods
5.2.1 Patient characteristics
Twelve patients with COPD and twelve non-smoking controls
were studied (Table 5.1). The COPD patients were all in a clinically
stable state, free from signs of decompensated cor pulmonale and
respiratory tract infection. All patients were ex-smokers. Three patients
■
were on regular diuretic therapy and two on anti-anginal drugs, one on 
nitrates and another on Diltiazem. None of the patients was on oral 
steroids or theophyllines at the time of study. All patients had been on 
inhaled beta agonists for at least the three yeai's preceding the study, 
taking at least 800|igms a day of salbutamol. Patients on oral salbutamol 
were not included in the study.
5.2.2 Study protocol
Subjects were studied in the morning in tlie fasting state.
IPatients were requested to abstain from using their usual beta agonist 
inhaler on morning of the study. Height and body weight were measured 
and after a rest of 30 minutes resting energy expenditure (REE) was 
measured by indirect calorimetry for 20 minutes. Following tliis all 
subjects were asked to inhale 800 qg of salbutamol via a spacer device
' H
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(Volumatic, Allen and Hanbuiys Ltd, United Kingdom) and calorimetry 
was continued for a further 30 minutes. During calorimetry pulse rate 
and oxygen saturations were monitored by a pulse oximeter (OXImeter,
Radiometer Ltd., Copenhagen). After the 30 m inute period subjects were 
asked to report any symptoms following the adm inistration of 
salbutamol.
5.2.3 Ind irec t calorim etry
Energy expenditure (EE) was estimated by indirect calorimetry 
using a ventilated canopy system (Deltatrac ™ Metabolic monitor,
Helsinki, Finland) as described in detail previously, measuring V 0%, V 
CO2  and respiratoiy exchange ratio (RER) (VCO2 /V O 2 ) every minute.
Energy expenditure (EE) was calculated by the Weir equation (Weir,
1949). The data obtained in the first five minutes spent inside the hood 
were discarded and artefacts produced by coughing were eliminated in 
the final calculations. Arterial oxygen saturation was monitored during 
the study to ensure that subjects, particularly patients, did not desaturate 
whilst inside the hood. Gas calibration was peifonned as described 
previously. The system was checked by a methanol burning test every 
week during the study period and the average RER values for the last 15 
minutes of a 30 minute methanol burning run were confirmed to be 
between 0.64 and 0.69. Flow calibration was performed once during the 
study period by calculating the total amount of CO2  produced during the 
methanol burning test and the flow constant adjusted if appropriate. REE
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was expressed both in absolute terms and as percentage of values 
predicted by the Harris- Benedict equation from age, sex, height and 
weight (Harris and Benedict, 1919).
5.2.4 Statistical analysis
On the basis of previous studies showing a 10-25% increase in 
V 0% following inhalation of salbutamol and previously available data on 
the variance of EE measures, it was estimated that a number of twelve 
subjects would have a power of greater than 90% in detecting a 5% 
change in EE following salbutamol administiation. Therefore twelve 
patients and an equal number of controls were studied.
Following salbutamol administration the mean of EE, V O2 , V 
CO2 , RER and HR measured in the three minutes around the 5, 10, 15 
and 30 minute marks (i.e., at minute 4,5 and 6 ; 9,10 and 11 etc.,) were 
taken as the values at 5,10, 15 and 30 minutes; based on these values the 
area under the curve (AUC) for the 30 minute period for each measure
was calculated (Matthews et al, 1990). Changes from baseline for each 
measure were also calculated in patients and controls and expressed as
1
mean change with 95% confidence intervals. Baseline measures and post 
salbutamol EE and HR (AUC) measures were compared in patients and 
controls by Mann-Whitney U test.). Changes in HR, V O 2 , V CO2  and
■RER were also compaied similaiiy. Significance was assessed at the 5% 
level. All statistical calculations were peifonned using a standaid
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computer software programme (MINITAB Release 9.2, Clecom Ltd, 
BiiTningham
AU subjects, including controls, had taken part in previous 
studies, were familial' with the calorimetry equipment and gave their 
informed consent.
5.3 Results
Mean (SE) REE was 102.1 (1.5)% predicted in patients and 
101.7 (1.5)% predicted in controls.
The trend of EE, HR, VO2 , VCO2 , and RER following 
inhalation of salbutamol in controls and patients are shown in Figures 5.1 
-5.4. In both patients and controls peak values for VO2 , VCO2 , RER 
and HR occun*ed at about 5 minutes after inhalation of salbutamol, in 
keeping with the known phaimacokinetic profile of the inhaled drug. The 
increases in VO2 , VCO2 , EE and HR were far greater in controls than in 
patients (Tables 5.2 and 5.3). Two controls and none of the patients 
complained of feeling anxious following salbutamol inhalation. Tremor 
was not observed in any of the subjects.
5.4 Discussion
Two conclusions of this study merit detailed discussion. 
Firstly, the study suggests that chronic p agonist therapy does not have 
an adverse impact on the energy balance of patients with COPD. Not
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only did the patients with COPD who were régulai’ users of inhaled 
salbutamol show no elevation of REE, in line with a recent report on the 
REE of patients on chronic beta agonist therapy (Congleton et al, 1994), 
they also showed a blunting of the acute thermogenic response to the 
drug. Secondly, the study also adds to the large body of evidence on the 
phenomenon of tolerance to the systemic, non-bronchodilator effects of 
beta-agonist drugs (Tattersfield, 1985). From these results it seems 
unlikely that regular inhaled beta agonist therapy leads to a state of
chronic hyper metabolism and negative energy balance in patients with 
COPD.
Whilst it is well established that beta adrenergic drugs
increase energy expenditure, how they do so is still unclear. Various
mechanisms, not mutually exclusive, may be in operation (Tattersfield 
and W ilding, 1994): (1) By their positive chronoti’opic and inotropic 
effect p agonists increase cai'diac output and hence EE by a direct effect 
on the heart, although increase in metabolic rate by any mechanism will 
lead to secondary elevations of heart rate and cardiac output; (2 ) by 
increasing the ventilatoi’y drive (Leitch et al, 1976) and (3) by 
augmenting muscular activity in the forni of a tiemor. In animals studies 
it has been shown that the thermogenic effect of beta agonists may be 
mediated by a specific category of beta receptors (P 3 receptors) which 
are believed to activate lipolysis in brown adipose tissue. The evidence 
for the existence of such a system in humans is incomplete and its precise 
role in thermogenesis is still unclear (Rosenbaum et al, 1993). The time
.................................       4-
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course of the increase in EE following salbutamol inhalation m inors the 
rise in heart rate closely and it has been suggested that the differential 
increase in V CO2  (and consequently of RER) seen after salbutamol
the lungs and resultant increase in ventilation, a phenomenon termed 
cardiodynamic hyperpnoea (Wasserman et al, 1974).
In a previous study, the acute thermogenic response to
"I
■ ï'v
I
inhalation is a manifestation of increased cai’diac output, CO2  flux into
I
y:
Î
salbutamol was abolished by régulai' use of the drug but this tolerance to 
the thermogenic effect was not accompanied by a diminished heart rate 
response (W ilson et al, 1994). In this study COPD patients on long term 
beta agonist therapy have shown not only a diminished thei’mogenic 
response but also a diminished chronoti’opic response to the drug,
perhaps suggesting that the thermogenic response to beta agonists is 
mainly the result of increased cardiac function.
It is of course possible that in patients, the blunting of the 
thei’mogenic response is due, at least in part, to the decreased energy 
expenditure resulting from the decreased work of breathing following 
bronchodilation by salbutamol. In this study the oxygen cost of breathing 
before and after salbutamol was not measured and thus data on the 
beneficial effect of salbutamol on the energy cost of breathing and on 
overall energy expenditure are not available. However under nonnal 
circumstances the work of breathing constitutes less than 5% of the total
■energy expenditure (M illie-Emili and Petit, 1960). Given that tlie patients 
were studied in a relatively stable state and that they also showed a
J
'■ïïï
150
blunting of the heart rate response to the drug it seems reasonable to 
conclude that tlie decrease in tliermogenic effect is a manifestation 
mainly of tolerance to the systemic effects of the drug rather than the 
result of a decrease in the energy cost of breathing, although this study 
has not measured the energy gain resulting from bronchodilation.
There are a few problems with this study that merit mention. 
Firstly, the control group is younger than the patient group and this 
limitation must be borne in mind in tlie assessment of this study. Other 
investigators have provided some evidence that there is an age related
I.
blunting of tlie thermogenic effect of beta agonists, and this may have 
accentuated the difference between patient and contr ol groups 
(Cnietzberg et al, 1994). Patients and subjects were studied only on one 
occasion the coefficient of variation for post salbutamol calorimetry 
measurements performed in three patients, although higher than that for 
resting measurements was still within acceptable limits (less tlian 1 0 %). 
Ideally, it still would have been preferable to study the subjects on two 
different occasions and to have confimied that the calorimetry 
measurements following salbutamol inhalation were repeatable in every 
subject. Also, it might have been valuable to have measured the 
thermogenic response to a placebo inhaler in patients and controls.
I
f
I 
.g
I
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5.5 Conclusions
In conclusion, this study has shown that the thermogenic 
response to inhaled beta agonist dings is diminished in patients with 
COPD who have been long term users of the ding. Blunting of the 
thermogenic response is associated with a blunting of the heart rate 
response, probably suggesting a systemic tolerance phenomenon. In view 
of the impaired thennogenic response to beta agonist drugs seen in these 
patients, it appears unlikely that drag induced hyper metabolism 
contributes significantly to the weight loss seen in COPD patients.
9
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Table 5.1
Chai’acteristies of study population. Values as Mean (SE).
COPD patients Controls
Number 12 1 2
Sex 7 males; 5 females 5 males; 7 females
Age (in years) 64. 8 (1.8) 53,6 (2.3)
FEV 1( as % predicted) 44.5 (4.5) 97.8 (1.3)
Height ( cm) 165 (3.1) 163.1 (3.7)
Weight (kg) 55.3 (4.0) 63.5 (3.5)
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Table 5.3
Increases in EE, V O2 , V CO2  and heart rate following 
salbutamol inhalation in controls and patients. Values as mean 
increase( 95% confidence intervals). ;#■
Controls Patients
Energy expenditure 
( kcal/ 24 h/ kg)
2.89 (2.3, 3.4) 0.62 ( 0.46, 0.78)
V O2  ( ml/ kg/ mill) 0.39 ( 0.32, 0.46) 0.09 (0.06, 0.10)
V CO2  (ml/ kg /  inin) 0.36 (0.30, 0.42) 0.07 (0 .03 ,0 .12 )
Heart rate ( beats/ min) 12.2 ( 11.1, 13.4) 1.2 (1.4,2.3)
*
I
■
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F igure 5.1 ; Changes in energy expenditure and heart rate in
controls following salbutamol inhalation.
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F igure 5.2: Changes in energy expenditure and heart rate in
patients after salbutamol.
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Figure 5.3: Changes in V O2 , V CO2  and RER in controls
after salbutamol inhalation.
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Figure 5.4: Changes in V O2 , V CO2  and RER in patients
after salbutamol inhalation.
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CHAPTER 6: Energy balance of patients 
hospitalised with an acute exacerbation of 
COPD
would be expected from tlie mere themiic effect of a fever; 
and that hypeiTnetabolism can accompany a state of
has been suggested that measurement of REE in such patients 
m ight be a useful indicator of secondaiy infections where 
other conventional clinical signs fail (Melchior et al, 1993).
6.1 Introduction
It is well recognised tliat metabolic stress 
related to injury and infection is associated with an elevation 
of the metabolic rate (Cuthbertson, 1954; Halmagyi et al, 
1974). Infection is usually accompanied by fever and it has 
been estimated that for each degree centigrade increase in 
body temperature, basal metabolic rate increases by 12% (Du
Bois, 1921). Other investigators have provided evidence to 
suggest that hypermetabolism in sepsis is greater than that
I
normothenriia in infection (Roe and Kinney, 1965; Halmagyi 
et al, 1974). In any event tlie view that infection elevates
:
energy expenditure is beyond dispute. Even in patients with an 
impaired immune response such as patients with Acquired 
Immune Deficiency Syndrome (AIDS), there is an aunequivocal thennogenic response to infection, such tliat it
i160
Patients with chronic aiiflow obstruction suffer 
from more episodes of respiratory tract infections than 
Contr ols (Monto et ai, 1975). The clinical picture of a patient 
with COPD gradually becoming progressively malnourished 
with each intercurrent illness, including respiratory tract 
infections, is well described (Bates,1973; Fig 1.5). Whilst this 
impression of infections adversely affecting the energy balance 
of patients with COPD and resulting in weight loss is in 
keeping with clinical experience, surprisingly little data exist 
on the exact effect of a respiratory tr act infection on the 
energy balance of patients with COPD.
In a study of the resting energy expenditure of 
eighteen elderly patients (mean age 84.9 yr.) hospitalised with 
a respiratory tract infection, investigators found that REE was 
elevated by 32.5 percent above that of healthy age matched 
contr ols (Hodkinson et al, 1990). Likewise a study of young 
patients with an acute infective exacerbation of cystic fibrosis 
revealed a significantly elevated REE which gradually 
decreased with antibiotic therapy (Naon et al, 1993). There
I
ii
are however no studies of REE in patients with COPD. Given
that infection is associated with an increased energy demand
I
and that patients with COPD suffer from more infections than 
average, the energy cost of respiratory tract infections could 
play a significant role in causing a state of negative energy
!
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balance and weight loss in these patients. This study was 
designed to quantify the state of energy balance in patients 
with COPD hospitalised with an acute infective exacerbation.
6.2 Patients and methods
Twenty patients adm itted to the Glasgow 
Royal Infir mary with an acute infective exacerbation of COPD 
were studied. An acute exacerbation was considered to be 
infective if the patient suffered from an increase in cough, 
sputum production and/ or breathlessness which was 
unresponsive to an increase in the use of bronchodilators, 
and/or fever, witli or without haematological, bacteriological 
or radiological evidence of acute infection.
6.2.1 Study Protocol
Twenty patients (10 male; 10 female) adm itted 
acutely unwell to Wards 10 and 11 of the Glasgow Royal 
Infirmary were studied (Table 6.1). Patients were studied 
within 36 hours of adm ission to the hospital. The 
investigations, including indirect calorimetry were performed 
in a separate room in the medical wards.
REE was estimated after an overnight fast on tlie 
morning after hospitalisation, and again on the day before 
discharge. In view of the results of tlie previous study beta 
agonists were not withheld on the morning of the study, but
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calorimetry was peifonned at least two hours after the last 
dose of beta agonists. Oxygen therapy was discontinued
antibiotics at the time of both the initial and subsequent
fifteen minutes before calorimeby. All patients were on
calorimetry. REE was expressed both in absolute values and
as percentage of values predicted by the Harris-Benedict 
equation (Hainis and Benedict, 1919).
.The respiratory rate and oxygen saturation 
breathing room air and body temperature (oral) were
measured whilst the patient was resting in tlie semi-recumbent
;posture. Oxygen saturation was measured by a pulse oximeter 
(Radiometer Ltd., Copenhagen). Prior to calorimetry, body 
weight, height and skin fold thickness were measured. The 
sum of the skin fold thickness at four standai'd sites was 
calculated and percentage body fat estimated from standard 
equations (Durnin and Womersley, 1974). Fat free mass was 
derived from this value and expressed in kilograms.
No specific bacteriological, haematological or 
biochemical tests were performed as part of the study. In 
those patients in whom C- reactive protein levels were 
estimated at the time of admission (n=13) as part of indicated 
clinical care, theses values were obtained. C- reactive protein
levels were estimated by a standard immunoassay technique 
(Olympus AU 5230).
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Patients who were grossly oedematous and patients 
who exhibited signs of decompensated cor pulmonale (raised 
jugular venous pressure) were not included in the study.
On the day before discharge the total dietary intake 
was recorded by a member of the nursing staff, with particular 
attention being paid to tlie portion sizes consumed. From this 
tlie calorific intake was measured by a previously validated 
computer based technique (Food Meter™ , Medi-Matica s.r.L,
San Benedetto Tr, Italy; McCance and W iddowson, 1991).
Energy balance was estimated by relating energy intake to 
total twenty- four hour energy expenditure, which was taken 
as 1.4 times measured REE (Department of Health, 1991).
AU patients gave their infonned consent and the
::i'ï
study was approved by the Glasgow Royal Infirmaiy Ethics
Committee.
6.2.2 Statistics
Changes in REE, weight, respiratory rate and
oxygen satiaation between adm ission and discharge were 
expressed as mean change with 95% confidence intervals. 
Conelation between variables was estimated by the Spearman
rank conelation coefficient. Stepwise multiple regression was
performed with REE as a dependent variable, fat free mass, 
C-reactive protein, lespkato iy rate and oxygen saturation as
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explanatory vaiiables. Significance was assessed at the 5% 
level. All statistical calculations were performed with the aid 
of a computer using a standard software package (MINITAB 
Inc., Clecom Ltd, Bhm ingham).
6.3 Results
The median duration of stay in the hospital was 5 
days (range 4 - 12).
6.3,1 Anthropometric and clinical measures
The baseline anthropometric and clinical 
chai'acteristics ai'e shown in Table 6.2. Seven patients had a 
body mass index of less than 18 kg/m There was no 
significant change in weight during the stay in hospital. There 
was however a significant fall in respiratory rate (mean fall 8 .8  
breaths /  minute; 95% Cl 7.4, 10.2); there was also an 
increase in resting oxygen saturation during stay in hospital
I
(mean increase: 2.9%; 95% Cl: 2.1, 3.6).
I6.3.2 Evolution of REE during the stay in hospital 
(Table 6.3; Figure 6.1)
REE was elevated above predicted values in all 
patients at the time of admission (Mean (SD) 115.4 (7)%).
It fell by 9.3 (95% Cl: 7.2, 11.5) of predicted values during 
the stay in hospital to 106.1 (4.5)%.
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On reü’ospective analysis of data, there was some 
suggestion that patients on maintenance steroid therapy (n = 
8 ), as a group, exhibited a lesser elevation in REE (112.8 
(5.9)% predicted) than those not on steroids (n = 12) (117.1 
(7.40)% predicted), altiiough this difference did not reach 
significance (p = 0.18) (Figure 6.2). In patients on steroid 
therapy there was no relation between dose of steroids and 
percentage predicted REE.
6.3.3 Dietary intake and energy balance at 
discharge
Dietary intake was very poor even on the day 
before discharge. Mean (SD) energy intake was only 895 
(518) kcal/ day, making for a net negative energy balance 
(calorific deficit) of 889 (296) kcal/day below predicted 24 hr 
energy expenditure (Figure 6.3).
6.3.4 Relation between REE and other variables
There was a strong relation between REE and C-
whom C-reactive protein measurements were available (r
REE or between respiratory rate, oxygen saturation and REE.
reactive protein levels on admission in the thirteen patients in
0.60; p <0.01) (Fig 6.4).
There was no relation between body temperature and
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The fall in REE during hospitalisation was strongly 
related to the initial elevation of REE above predicted levels
i.e., higher the initial REE above the predicted value, greater 
the fall witli treatment (r = 0 78).
On multiple regression analysis, fat free mass alone 
accounted for 65.9% of the variation (R^) in REE on 
admission, C-reactive protein and FFM increased explained 
variance to 79.7%. The addition of respkatory rate or oxygen 
saturation did not improve this, although FFM and respiratory 
rate on admission gave an R^ value of 75.6%.
6.4 Discussion
This study confiims the clinical impression that
COPD patients suffer a state of considerable negative energy 
balance during an acute infective exacerbation. The study has 
not only quantified the degiee of imbalance but has also 
shown that both the increased resting energy expenditure 
stemming from sepsis and a profound depression of food 
intake during the acute illness contiibute to this state of 
energy imbalance. Whilst the main finding as regards negative 
energy balance during the acute illness is unsurprising, there 
are certain aspects of the study that merit discussion.
Although the patients were in a state of negative 
energy balance during their stay in hospital, they did not
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exhibit any major weight loss. This could be due to two 
reasons. One, the short duration over which the measurements 
were made (median stay was 5 days; tlie interval between 
weight measurements was four days in most cases) meant that 
major sustained changes in body cell mass were less likely to 
have occuiTed. A negative energy balance of 1000 kcal /  24 hr 
for five days would result in a loss of under 1 kg, assuming 
that 75% of the loss is fat. This is still within the range of day- 
to-day fluctuation in weight. The other possibility is that, 
although patients were not overtly oedematous, there may 
have been a degiee of right heai’t failure and fluid retention 
during the acute exacerbation which naight have confounded 
the use of weight as an indicator of body cell mass. In this 
regard the fact that all patients with an acute infective 
exacerbation of COPD were either already on or were placed 
on steroid therapy immediately after hospitalisation is of 
relevance, as steroids are a well recognised cause of fluid 
retention and could conceivably have resulted in maintaining 
weight, masking the loss of body cell mass (Hayes, 1990).
The effect of steroid therapy on the results of the 
study aie also worthy of some discussion. The patients who 
were on maintenance steroid therapy (doses of 5-20 
milligi'ams of Prednisolone) showed a slightly lesser elevation 
of REE than tliose patients who were not on maintenance
the anorexia associated with infection (Tracey et al, 1989) and
breathlessness and oxygen desaturaion caused by the effort of
I
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steroids. Although corticosteroids are catabolic as regai’ds 
intennediate protein metabolism, and have been shown to 
worsen nitrogen balance in arthritic patients even when 
producing signs of clinical improvement (Roubenoff et al, 
1990), their marked anti-inflammatory effect (Hayes, 1990) 
may well have resulted in a suppressive effect on REE. The 
numbers in each gioup aie too small for any conclusions to be 
drawn in this regcU'd. But with the increasing use of steroids in 
COPD thek effect on energy balance, body composition and 
natural history of the disease, in pai ticular, them well 
recognised ability to mask the depletion of fat free mass merit 
further study.
In contrast to the study of patients with cystic 
fibrosis (Naon et al, 1993), the patients in this study did not 
show any increase in weight during their stay in hospital 
whilst recovering from the acute illness. This is due to the fact 
that, whereas the dietaiy intake of the young cystic fibrosis 
patients gradually increased during their stay in hospital, the 
calorific intake of this gi'oup of COPD patients remained very
poor even up to the time of discharge. One of the factors that 
could account for this very low dietary intake, in addition to
its treatment (anorectic effect of antibiotic), is the
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eating in these patients with severely compromised lung 
function (Brown et al, 1983; Schols, 1992). It was also 
noticed that the most common method of oxygen delivery 
used in the wards was a face mask, which cannot be used 
whilst eating. It would be a matter of interest whether the use 
of nasal cannulae , which allow eating, in place of oxygen 
masks, improves food intake.
The lack of relation between FFM and the increase 
in REE associated with an infective exacerbation may be 
inteipreted as suggesting that patients who aie nutritionally 
depleted do not show a relatively gieater increase in REE 
during an exacerbation. This lack of difference between 
undernourished and well nourished COPD patients as regards 
the energy cost of an infection could be taken as evidence that 
variations in the thermogenic response to an infection (and by
f
implication any other stress) is not the reason behind some
patients with COPD exhibiting negative energy balance and
cannot be made with certainty from this study due to the
(4 out of 13).
j.i
weight loss whilst others do not. However such a conclusion
confounding effect of steroid therapy; slightly more of the 
underweight (BMI less than 18) patients (4 out of 7) were on 
maintenance steroids than the normal or overweight patients
;g:
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6.5 Conclusion
The study comprising this chapter has shown that 
(a) patients with COPD suffer a state of considerable negative 
energy balance during an acute infective exacerbation; this 
could contribute to the weight loss seen in some of the 
patients (b) there was no evidence to suggest that the more 
nutritionally depleted patients exhibit an ‘inappropriate’ 
increase in REE compared with the well noui’ished (c) steroid 
therapy, which is being increasingly used in COPD, is likely to 
be a major confounding factor in future studies of energy 
balance and body composition of patients with COPD.
I
Î
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Sex 10 male; 10  female
Age (yr.) 66.0 (4.8)
Smoking history 18 ex-smokers; 2 cuiTent smokers
Drug therapy
Inhaled therapy:
Beta agonist 2 0 ( 1 0 0 %)
Steroids 12  (60%)
Oral therapy:
Steroids 8 (40%)
Aminophylhnes 1 (5%)
Diuretics 7 (35%)
Nitrates 3 (15%)
Diltiazem 2  (1 0 %)
T a b le  6 .1 : Characteristics of study population. Age as mean 
(SD)
172
Body weight (kg) 55.4 (16.0)
Height (cm) 159 (8.0)
Body mass index 2 2 .1  (6 .1)
Fat free mass (kg) 38.3 (3.2)
Clinical data Admission Discharge
Respiratory rate (breath/min) 26.7 (2.9) 17.1 (2.5)
Oxygen saturation (as%) 85.8 (5.1) 88.7 (3.9)
C- Reactive protein (n=13) 56.3 (25.3) NA
T a b le  6 .2 : Anthropometiic and clinical chai’acteristics of 
patients adm itted with an acute infective exacerbation of 
chronic obstructive lung disease. Values as mean (SD). 
NA - not available
IIA::;
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Figure 6.1 : Changes in REE (as percentage predicted) 
during stay in hospital in twenty patients admitted with an 
acute exacerbation of COPD.
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F ig u re  6 .2 : REE on adm ission (as percentage predicted) in
patients on maintenance steroid therapy at the time of 
admission and those not on maintenance steroid therapy.
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CHAPTER 7: Routine and novel 
outpatient nutritional programmes in 
COPD
7.1 Introduction
The logical extension of the obsei*vation that
malnutrition was an adverse prognostic factor in patients with 
COPD was the attempt to restore the nutritional status of 
these patients witli a view to improving the morbidity and 
mortality. The question of nutiitional support in these patients 
and in particulai' its effect on their lung function, respiratory 
muscle strength (RMS) and exercise capacity has been well
;";ï
reviewed (Fitting and Spiro, 1991). Studies which showed an f
improvement in RMS and exercise capacity following
nutritional supplementation involved intensive short-term
refeeding techniques (Wilson et al, 1986)) or closely
supervised outpatient programmes (Efthimiou et al, 1988;
Rogers et al, 1992) witli significant cost implications.
However, if nutritional therapy is to have a practical role in 
rehabilitation programmes for COPD, simple outpatient 
programmes are required. Although studies have investigated 
outpatient provision of nutritional supplements in COPD, 
supplementation in these investigations has usually been
I
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caiTied out under research conditions involving intensive use 
of dietary advice and follow-up. In this context it was felt that 
a study of a simple, sustainable outpatient nutritional support 
programme, delivered in a clinical setting w ithout tlie benefit 
of research programme based resources, would help clarify 
the clinical role of nutritional support in COPD patients.
7.2 Patients and methods
7.2.1 Patient characteristics
Twelve patients (9 male, 3 female; mean age
65.9 yr.) (Table 7.1) were studied as outpatients. All patients 
had emphysema as manifested by a an FEVl/FVC of less than
■rf.60% predicted and a carbon monoxide single breath diffusing
capacity of less than 60% predicted (Gelb et al, 1983). All 
patients were less than 90% ideal body weight (IBW) as 
determined from the m idpoint of the weight range for sex, 
height and frame in tire Metropolitan Life Insurance Company Ï
stables (Metropolitan Life, 1983) or had lost more than 5 
kilograms in the previous year. All patients were ex-smokers.
None of them suffered from cancer, diabetes, malabsoiption 
or any other illness that could cause weight loss. Patients who 
suffered from overt cor pulmonale (ankle oedema, raised 
jugular venous pressure) or other cardiac disease were 
excluded from the study. Patients entered into the study were 
considered clinically stable and free of intercurrent respiratory i
using standard techniques (Durnin and Rah aman, 1967). M id­
circumference (MAMC) derived.
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tract infection. All patients used inhaled and/or oral 
bronchodilator therapy. None was receiving oral steroid 
therapy but four patients were on long term inhaled steroids 
(more than 2  yr.) at a dose of less than 800 micrograms of 
beclomethasone dipropionate a day.
7.2.2 Anthropometry
Body height was measured to the nearest 0,5 cm with
the patient standing barefoot; body weight was measured to
tlie neai*est 0 .1  kg by a beam scale with the patient in light
clothing and without shoes (Weylux Model 424, England).
Body frame was estimated from wrist circumference
»measurements. Triceps skinfold thickness (TSF) was 
measured to the nearest 0.2 mm by Holtain skinfold calipers
SI
ann circumference (MAC) was measured and m id-ann muscle
I
7.2.3 Blood biochemistry
Serum albumin was measured. C-reactive protein levels
were estimated as an indicator of the presence of an acute 
phase response.
7.2.4 Calorimetry
Indirect calorimetry was performed on an outpatient
aIbasis in all patients using a ventilated hood system (Deltatrac metabolic monitor, Datex instiumentarium Coi-poration, 
Helsinki) as previously described (Chapter 2). Patients were
I
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tested in a sepai’ate laboratory after an overnight fast of at 
least 10 hours. After a resting period of 20 minutes oxygen 
consumption and carbon dioxide production were estimated 
for a period of 2 0  minutes with the patient in the semi- 
recumbent position. The data obtained in the last 15 minutes 
was used to estimate resting energy expenditure (REE) if 
there was less than 5% minute to minute variation in the 
oxygen consumption measurement. REE was calculated using 
Weir's formula (Wek, 1949).
7.2.5 Lung function tests and exercise capacity :
Forced expiratory volume in the first second (FEV 1)
and forced vital capacity (FVC) were measured using a whole 
body plethysmograph (P.K.Morgan Ltd, England) (Grimby 
and Soderholm, 1963). Diffusing capacity was measured by 
the single breath technique (B uitows et al, 1961). Maximal 
inspiratory and expiratory moutli pressures (PI max and PE 
max) were measured using appai'atus based on Black and 
Hyatt (Black and Hyatt, 1969). P I max was measured fiom 
functional residual capacity (FRC) and P E max fi'om total 
lung capacity (TLC). The highest of tlu'ee technically 
satisfactoiy measurements was taken as the value used for
analysis in each case.
Symptom limited exercise tests were carried out using 
an electiically braked bicycle ergometer (Siemens Ltd) with 
the patient breathing tlirough a low dead space low resistance
I
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valvebox. The valve box incoiporated a turbine ventilometer 
on the inspired limb for the measurement of ventilation. 
Expired gas was analysed for oxygen (0%) and cai'bon dioxide 
(CO2 ) by an infra-red spectrometer and para magnetic 
analyser respectively (P.K.Morgan Ltd, England). After a 2 
minute rest period while seated on the bicycle the patients 
were instructed to cycle with no additional load for 2  minutes. 
Thereafter the load was increased by 25 watts eveiy 2 minutes 
untd symptoms limited exercise. Two ti'ial tests were 
performed on separate occasions before the fkst exercise test 
to fainiliai'ise the patients with the equipment and avoid 
confounding of the results by a training effect.
The measures of respiratory function, exercise 
capacity and nutiitional status were made before and after a 
four month period of nutiitional support.
7.2.6 Dietary assessment and nutrition
The patients were assessed by a senior dietician on 
enrolment into the study. Mean daily carbohydiate, protein, 
fat and energy intake was estimated from a 7 day recall on 
two separate occasions. The patients were then advised on 
increasing their total caloric intake to at least 50% above 
predicted daily energy expenditure, which was calculated as 
1.4 times REE (sedentary lifestyle); recommended protein 
intake to at least 1.5 g/kg . Nutritional supplementation was 
by the use of proprietaiy supplements. The patients were
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allowed to choose tlie nature (liquid, pudding) and flavour of 
the supplements from a wide range of proprietary 
preparations (Buildup, Fortisip, Maxijul R). A fortnight's 
supply of tlie supplement was provided initially and the 
patients were asked to seek replenishments as required.
Where applicable the patient's spouse was also instructed on 
the aims and nature of the dietary intervention. After the first 
inteiview the patients attended a monthly dietetic review 
when adherence to the recommended diet was confinned 
verbally. Nutritional supplementation was continued for a 
period of four months. The dietaiy advise was provided 
during routine clinic hours.
7.2.7 Statistical analysis
The anthropometric measures, serum albumin, tests 
of lung function, exercise capacity and RMS before and after 
nutritional supplementation were compared using paiied 
Student's't' test. The mean values of the vai'ioiis 
measurements were considered significantly different when 
the probability of the differences of that magnitude, assum ing 
the null hypothesis to be conect, fell below 5% (i.e. p < 0.05).
The study was approved by the hospital ethics 
committee and the patients gave their infomned consent.
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7.3 Results
Three patients withdrew from the study. Two
patients w ithdrew due to intolerance of the supplements, one 
after the first fortnight and another after a month. 
Unacceptable taste and abdom inal bloating after taking the 
supplements were given as reasons for intolerance to the 
supplements by the two patients. One patient w ithdiew due to 
a protracted episode of intercurrent lower respiratory tract
infection.
Mean resting energy expendituio for the group 
was 109.3% predicted (Range 96 - 126). Nine of the twelve 
patients were in a state of net negative energy balance (Table 
7.2). O f the nine patients a weight gain of more than 1 
kilogram was achieved in only three and these patients were 
from a higher socio-economic class (Class I and II) than the 
patients in whom nutiitional supplementation was 
unsuccessful (Class IV) (Office of Population censuses and 
Surveys, 1980).
There was no significant change in the nutiitional 
status, FEY i, RMS or VO2  max after the four month period 
of supplementation in the nine patients who completed the 
study (Tables 7.3 and 7.4; Figures 7.1 and 7.2).
:
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7,4 Discussion
Well designed, randomised, controlled studies
have shown that successful nutritional therapy is accompanied 
by an improvement in various measures of respiratory 
function and symptoms (Wilson et al, 1986; Eftliimiou et al, 
1988).The aim of this unconholled study was to see whether 
the beneficial effect of supplementary nutritional therapy as 
demonstrated under well controlled experimental conditions 
could be extended to the wider ai'ea of clinical practice. The 
study suggests that although weight gain and improvement in 
functional status may be achieved by some individuals under 
these circumstances, this approach is ineffective for the 
majority and a number of practical issues need to be addressed 
before nutritional therapy is accepted as routine clinical 
practice.
All studies of outpatient nutritional support in 
malnourished COPD patients, tire present study included, 
point to the fact that these patients are unable to maintain an 
increased caloric intake over a long period. In one of the more 
recent studies (Rogers et al, 1992) the rate of weight gain 
achieved during stay in a clinical research unit could not be 
sustained in the outpatient setting despite the provision of full 
and intensive nutritional support. Thus, providing adequate 
and appropriate nutritional support alone does not in itself
185
guar antee an improvement in the nutritional status of these 
patients.
A number of factors could account for this 
rinding. It has been pointed out tliat patients tend to decrease 
their own food intake whilst receiving enteral formulas and do 
not in fact improve their caloric intake while on nutritional 
supplements (Lewis et al, 1987). Breathlessness produced by 
the effort of eating may also limit food intake. Perception of 
nutritional therapy as making only a m inor contribution to 
their well being might be another factor that may influence 
compliance with dietary advise and response to tlierapy. No 
attempt was made in this study to objectively conrimr
adherence to the dietary instructions provided as it was felt
that under clinical conditions, which the study aimed to 
mimic, such measures would be cleaiiy impractical.
Perhaps worthy of some note is the finding that 
the three patients who gained weight in this study were from a 
higher socio-economic class, Classes I and II. Unemployment, 
smoking habits, poor working and housing conditions are 
amongst the various factors that may influence the outcome of 
all medical treatment including nutritional therapy (Whitehead 
and Dahlgren, 1991).
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7.5 Conclusion
Conventional nutiitional supplementation
provided for four months via a routine dietary clinic does not 
improve nutiitional status, lung function or exercise capacity 
in malnourished COPD patients. In line with a recent study in 
the same field which concluded that although nutiitional 
tlierapy is capable of producing significant clinical 
improvement in patients with COPD, it is ‘costly, time­
intensive and of limited therapeutic magnitude’ (Rogers et al,
1992), this study leads to the conclusion that nutritional 
supplementation per se is of little value in the management of 
patients with COPD, Clearly, further studies in the outpatient 
setting should now assess the effect of nutritional therapy in 
conjunction with attempts at promoting anabolism either by 
phaniiacological means (anabolic steroids) (Schols et al,
1992) or physical training (exercise prescription and 
respiratory muscle training).
One of these, the use of novel anabolic agents, is explored in 
the following section of this chapter.
I:
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7.6 Clenbuterol : Introduction
Clenbuterol is a sympathomimetic agent which has 
bronchodilator properties and has been used in the treatment 
of airways obstruction (Brusaco et al, 1980). In addition the 
drug has been shown to increase skeletal muscle protein as
:well as muscle fibre size and strength. These effects have been 
documented in normal muscle tissue (Maltin, Delday and 
Reeds, 1986; Zeman et al, 1988), denervated muscle (Maltin 
et al, 1986) and immobilised muscle (Delday, Williams and
'
Maltin, 1990). Following animal studies suggesting an 
anabolic effect, the di’ug was studied as a muscle specific 
anabolic agent in improving muscle sti'ength in a group of 
patients recovering from orthopaedic (knee) surgery (Maltin 
et al, 1993). Clenbuterol treatment was associated with a 
more rapid rehabilitation and an increase in knee extensor 
strength in the unoperated side, lending support to the view 
that the diaig might have a role to play in the management of 
disease states associated with muscle wasting. Given that 
some patients with COPD exhibit depletion of muscle mass 
and that clenbuterol, in addition to its well documented 
bronchodilator effect also has an anabolic effect on muscle 
tissue, it was considered appropriate to conduct a random ised, 
double blind, placebo controlled pilot study of this drug in 
malnourished patients with COPD.
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7.7 Clenbuterol study: Patients and methods
Six patients were studied (four female, two male; mean age:
64.5 yrs; range: 47-76). All the patients suffered from 
emphysema (Gelb et al, 1983) and had a body mass index <
18. All the patients had taken pait in routine nutritional 
supplementation progi'amme described above and had failed 
to improve. Patients with significant p iimaiy (i.e. not cor 
pulmonale) heai't disease, hypertension and significant skin 
disease were excluded from the study in view of the known 
side effect profile of clenbuterol. There was no restriction on 
inhaled bronchodilator use but patients on oral p-agonist 
therapy were excluded.
After a 2 week run-in period patients were 
random ised to receive placebo or clenbuterol 2 0  jig twice 
daily for 4 weeks. After a 2 week washout period patients 
crossed over to the other ti'eatment. Follow ing 4 weeks of the 
second treatment patients underwent final investigations 
(Figure 7.1; Table 7.4). The dietaiy intervention during the 
two phases of the study was exactly the same as in the 
previous study, consisting of dietaiy advice with the provision 
of ad libitum supplements chosen by the patients (Section 
7.2.6).
The various investigations performed are 
summarised in Table 7.iJ. In view of tlie reseivations 
expressed by some of tlie patients in undergoing a formal 
exercise test, involving the measurement of V 0% max, a
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simple six minute walking test was used to assess exercise 
capacity (Section 2,6.4). Body composition was measured by 
whole body K 40 measurements (Chapter 2; Section 2.5.5). In 
addition to respiratoiy muscle strengtli, peripheral muscle 
strength was measured by handgrip dynamometry (Section 
2.7).
Statistical analysis was perfoirned using 
W ilcoxon signed rank test for changes in values from baseline 
after placebo and clenbuterol tlierapy.
7.8 Clenbuterol study: Results
Of the six patients one patient withdi'ew from the
study owing to unacceptable side effects from clenbuterol 
(severe pounding headache and anxiety; code unblinded). The 
results of the vaiious investigations of nuti itional status, 
respiratoiy function and exercise capacity are given in Tables
7.5 and 7.6.
As shown there was no improvement in any of the pai ameters 
in the group as whole, although one patient showed a striking 
increase in exercise capacity following the active di’ug (Patient 
no:5).
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7.9 Clenbuterol: Discussion
The result of this pilot study of clenbuterol in six
malnourished COPD patients is disappointing. The addition of 
tills agent with proven anabolic and ‘repartitioning’ effect to 
routine nutiitional supplementation did not improve the poor 
results obtained from simple supplementation alone.
It is possible that 4 weeks was too short a period for a 
tangible effect on muscle sti’ucture and function to be 
discernible. But other studies in humans have used the same 
time frame and demonstiated an improvement (Maltin et al, 
1994), and indeed it was the latter study and the advice of its 
principal investigator that was basis for the decision to study 
the drug for a 4 week period. A study of the drug given for a 
longer duration will clearly settle this issue and such a study is 
being planned.
It is also possible, indeed probable, that clenbuterol is 
relatively ineffective in severe pathological states and that its 
beneficial effect, particularly on muscle strength indices, is 
best seen in muscle tissue which is characterised by a normal 
metabolic state. Evidence for this assertion comes from the
previous study in humans, where the improvement in muscle
'strength in patients undergoing knee surgery was seen, not in 
the thigh muscles operated upon, but on the unoperated side.
Also a more recent study (M ilhken et al, 1995) in a mice 
muscular dystiophy model has shown that diaphragm
I
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dysfunction induced by threshold loading was not influenced 
by clenbuterol therapy, whilst in control mice clenbuterol 
improved the contractile properties of the diaphragm. It is
Ithus likely that the benefits of clenbuterol demonstrated in 
isolated muscle prepaiations may not, for reasons that are as 
yet unclear, extend to disease states.
I7.10 Conclusion
The addition of clenbuterol at a dose of 20 \i gms twice
daily for a month to a conventional nutiitional 
supplementation programme did not improve nutritional 
status, respiratory function or exercise capacity in a group of 
six malnourished emphysematous patients. It is possible that 
use of the drug for a duration longer than one month may 
better outcome but evidence is beginning to emerge that the 
muscle performance enhancing effect of clenbuterol may be 
limited to ‘normal’ muscle rather than disease states.
s
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No: Age
(yr.)
Sex % I B W REE kcal /  day 
(% predicted)
Daily caloric 
intake (%pred. 
daily EE)
1 79 M 89 1225 (108) 1899 (119)
2 64 F 70 1024(111) 1387 (104)
3 72 M 82 1087 (96) 1554 (110)
4 65 F 71 1187 (112) 1635 (106)
5 67 M 92 1484 (126) 1982 (103)
6 67 M 76 1358 (1100 1617 (91)
7 64 M 84 1630 (108) 2159 (101)
8 60 M 6 6 1039(114) 1337 (98)
9 67 M 92 1285 9109) 1798 (107)
10 60 M 85 1515 (117) 1890 (97)
11 64 F 82 1057 (99) 1516 (110)
1 2 62 M 77 1051 (102) 1270 (93)
Table 7.1 : Chai-acteristics of patients studied in an 
investigation of outpatient nutritional support in COPD.
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Enüy into study
li
Baseline investigations*
2 week loin-in 
Repeat investigations 
Randomisation
U II
Clenbuterol Placebo
u
4 weeks
II
Investigations *
2 week washout
II
Investigations
It
Cross-over
II
4 weeks
It
Investigations 
* See Table 7.4
F ig u re  7.1 : Clenbuterol study protocol
199
CHAPTER 8: Conclusions and future 
directions
Tills chapter summarises and brings together the 
results of die various investigations into aspects of energy 
balance of patients with chronic lung disease and reviews 
other new developments in the field. An attempt at providing 
a unified tiieoiy to explain the weight loss and energy 
imbalance seen in patients with chronic lung disease follows, 
taking into account the findings of die presented 
investigations and other new evidence gathered during the 
period of these investigations were in progress. The chapter 
concludes with a brief note on the directions that future
8.1 Results of investigations comprising
this thesis
The results of the vaiious investigations that
constitute this thesis are presented as answers to the specific 
questions posed in the first chapter.
vi
research in this subject could profitably undertake.
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8.1.1 Resting energy expenditure of patients with 
chest wall disease
Patients with chest wall disease are known to suffer 
from a mechanical inefficiency of the chest bellows mechanism 
and exhibit an increase in the work of breathing. The question 
posed was ‘Does the increased work of breathing which is 
recognised to be a feature of patients with chest waU disease 
always elevate resting energy expenditure?’.
A study of REE in twenty patients with chest wall 
disease (eleven post-TB thoracoplasty and nine scoliosis) 
showed that patients with chest wall disease do not exhibit a 
consistent increase in REE despite an assumed increase in the 
work of breathing.
8.1.2 Relation between REE, oxygen cost of 
breathing and nutritional status in patients 
with emphysema and chest wall disease.
The previous study had shown that REE was not 
elevated in patients with chest wall disease despite an assumed 
increase in the work of breathing; however, no measurement, 
dii'ect or indii'ect, was made of the energy cost of breathing. 
The next study of the thesis involved the measurement of the 
oxygen cost of augmenting ventilation and was designed to 
answer the question ‘What is the relation between the oxygen 
cost of breathing, lung function, REE and nutritional status in
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patients with different types of chronic respiratory 
impahinent?
In a study of twelve patients with chest wall 
disease (six scoliosis and six thoracoplasty), six patients with 
emphysema it was found that whilst the oxygen cost of 
breathing was inversely related to lung function, there was no 
relation between oxygen cost, REE and the nutritional status 
of these patients. Increased oxygen cost of breathing and poor 
lung function did not predict a hypermetabolic state or poor 
nutritional status. These findings render untenable the theory 
that tlie increased energy cost of breathing is the sole or major 
cause of weight loss in patients with clnonic lung disease.
8.1.3 Thermogenic effect of p agonist therapy
Adrenergic dr ugs are known to cause a dose 
dependent increase in energy expenditure. This thermogenic 
effect is apparent even when low doses of the drug are 
inhaled. The next study of the thesis addressed the questions 
‘What is the tliemnogenic effect of therapeutic doses of 
inhaled salbutamol in patients with COPD who aie long term 
users of the drug ?’ and ‘Is it possible that the thermogenic 
effect of beta agonist therapy contiibutes to a state of 
negative energy balance in these patients?’.
In a study of twelve patients with COPD who had 
been using inhaled salbutamol for over three years it was
I
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found that, compared with healtliy volunteers, these patients 
showed a marked blunting of the thermogenic and heart rate 
response to therapeutic doses of inhaled salbutamol. It was 
concluded that the them iogenic effect of beta agonist therapy 
was not a factor contiibuting to weight loss in patients with 
lung disease.
Î
8.1.4 Energy cost of acute exacerbation of disease
Although acute infective exacerbations have long 
been considered to contribute to a state of negative energy 
balance and weight loss in COPD patients, there are very few 
data on the subject. The next study of the thesis was 
conducted to answer the question ‘ W hat is the impact of an 
acute infective exacerbation on the energy balance of patients 
with COPD?’.
Indirect calorimetry performed within 36 hours of 
admission to hospital in 20 patients with an acute 
exacerbation of COPD showed that REE was not only 
significantly elevated at the time admission but that patients 
were in a state of significant negative energy balance even at 
the time of dischai'ge from hospital. The conclusion was that 
tlie energy cost of an acute infective exacerbation could make 
a significant contribution to cachexia in COPD.
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8.1.5 Renutrition in COPD
Investigators who have succeeded in demonstrating
a benefit in terms of improvement of nutritional status and 
lung function in malnourished patients with COPD have done 
so employing cost and labour intensive supplementary feeding 
techniques under research conditions. If refeeding is to have a 
clinical role in the management of COPD patients it must be
delivered by a simple and sustainable means, in a clinical
■3
setting. The concluding studies of the thesis were designed to 4
answer the questions: Î
1(a) Can successful renutiition and improvement in lung 
function be achieved by supplementation programmes 
delivered from a routine dietaiy clinic? and (b) W ill the use of 
the agent Clenbuterol, a beta agonist with muscle perfonnance 
enhancing properties, better the rather poor results obtained 
by routine nutritional supplementation studies? i
, '4The results of the refeeding studies, with and
without Clenbuterol, much like many of the more clinically 
orientated studies carried out previously, were disappointing.
A routine dietetic clinic based nutrition programme did not
Iimprove nutritional status, respiratory function or exercise 
capacity patients in a group of twelve malnourished COPD 
patients. The addition of Clenbuterol to nutritional
Isupplementation did not improve matters; a random ised
f
double blind, cross-over pilot trial of Clenbuterol plus
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nutritional supplements for a month in six patients showing no 
improvement in resph’atoiy function, exercise capacity or fat 
free mass compai*ed with nutiitional supplementation alone.
In summary tlie investigations of this thesis have 
provided evidence to suggest that the energy cost of breathing 
and them iogenic effect of beta adrenergic drugs are not 
important causes of energy imbalance and weight loss in 
patients with chronic lung disease; that an acute infective 
exacerbation of disease results in a significant state of energy 
imbalance which might contribute to weight loss in patients 
with COPD; and that routine dietary supplements given for 
four months and the drug Clenbuterol plus nutritional 
supplements given for a month do not improve nutritional 
status, respir atory function or exercise capacity in
malnourished COPD patients.
.
8.2 Results of other investigations in the 
field
During the time that the investigations that 
constitute this thesis were being pursued other workers have 
made significant contributions to the body of knowledge on 
this subject of nutritional status of patients with COPD. In 
particular', studies utilising techniques of molecular biology 
have uncovered interesting new evidence that may enable a 
coherent hypothesis to be foi’inulated to explain the weight
:,4
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loss that is a feature of patients with emphysematous COPD. 
This section summarises the results of these and other recent 
investigations in the field.
8.2.1 W eight loss in COPD and  cytokines
Cytokines are a group of hormone-like non antibody 
proteins released by one cell population which act as 
intercellular’ mediators in the generation of the inflammatory 
response (Billingham, 1989). Tumour Necrosis Factor (TNF)
- a  is a cytokine which is a primary mediator of injury and 
inflammation and provokes cachexia in a variety of clinical 
states including cancer (Tracey, Vlassai’a and Cerami, 1989). 
Recent studies have revealed that serum levels of TNF - a  are 
high in weight losing but not weight stable COPD patients (Di 
Francia et al, 1994). Other investigators have shown that not 
only are circulating levels of cytokines higher in weight losing 
COPD patients but also that, compared with healthy elderly 
controls, monocytes from these patients produce a larger 
amount of cytokines both spontaneously and in response to 
stimulation (de Godoy et al, 1994). From these studies it 
appears that cytokines, in particular, TN F-a has a role to play 
in the pathogenesis of weight loss in COPD. Also of interest 
in this subject is the observation that priming of human 
monocytes by hypoxia in vitro results in an enhanced release 
of cytokines (Bain et al, 1994).
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8.2.2 Nutritional depletion and gas exchange
Cany ing on from their observation that use of 
depletion of muscle mass as an indicator of malnutrition 
uncovers more cases of malnutrition than the conventional 
measure of total body weight, the Dutch workers have now 
presented the results of a study on the relation between 
nutritional depletion and respiratory and peripheral skeletal 
muscle function (Engelen et al, 1994). In a study of seventy 
two patients with COPD they have shown that depletion of fat 
free mass was associated with diminished respiratory and 
peripheral muscle strength. More interestingly they observed 
that whilst the nutritionally depleted patients did not show a 
pronounced difference in spirometry or intrathoracic gas 
volumes compared with tire well nourished patients, the 
transfer coefficient (K co) was significantly lower in the 
depleted group. In other words severity of airflow obstr'uction 
as measured by sphometry and body plethysmography did not 
discriminate between well and poorly nourished patients but 
measures of gas exchange i.e. the tr’ansfer coefficient (K co) 
did. This finding is entirely in keeping with the conclusion 
made in the fh'st chapter of the thesis that it is not severe 
airflow obstr'uction per se drat is associated with weight loss 
and malnutrition, but the gas exchange abnormalities that 
characterise emphysema.
Î
a
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depletion must account for the now well confinned 
observation that the best predictor of poor nutritional status
8.3 Energy balance and weight loss in 
COPD - a unified theory
Why do COPD patients suffer from weight loss? 
And why is weight loss more a feature of emphysema and its 
attendant abnormalities of gas exchange rather than of chronic 
bronchitis and severe airflow obstruction alone? Why is 
weight loss a poor prognostic sign? Why are COPD patients 
relatively refractory to nutritional repletion?
Until recently the most widely accepted theory 
explaining weight loss in patients with lung disease was the 
mechanistic one - airflow obstr uction causing an increase in 
the work of breathing, increased energy expenditure, negative 
energy balance and weight loss. However, the finding of the 
studies in this thesis that there is no relation between the 
oxygen cost of breathing, resting energy expenditure and 
nutritional status and the results of other studies on energy 
balance in patients with COPD (Ryan 1992, Green and Muers,
1993) render untenable the theory that the work of breathing 
is the main cause of weight loss in patients with lung disease.
Any theory which seeks to explain the tissue
ï-
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and low body weight in COPD is not the degree of airflow 
obstruction, as m ight be expected if it simply the work of 
overcoming airways resistance that leads to negative energy 
balance and weight loss, but the abnormality of gas exchange 
as measured by the transfer coefficient (K co). This implies 
either drat the protease - and pro tease imbalance that results 
in destruction of the alveolar walls, causing emphysema and 
gas exchange abnormalities, also causes protein destruction at 
a systemic level i.e., emphysema is a state of generalised 
tissue destr'uction of which the lung damage is only a part ; or 
that the generalised tissue depletion is the result of the 
abnormal gas exchange which is a characteristic, defining 
feature of emphysema (Gelb et al, 1973).
There is evidence to suggest that the latter is the case.
Riley and co-workers in their meticulous study (1968) 
showed that the underweight pink puffers, compared w ith the 
blue bloaters, had a lower cardiac output at rest and also 
failed to increase theh* caidiac output significantly on exercise, 
in keeping with the pathology of emphysema which involves 
destruction of the alveoli and disruption of the pulmonary 
vascular b e d , resulting in a relatively fixed cardiac output.
Thus whilst resting arterial oxygen tensions were higher in the 
thin, emphysematous pink puffer, tissue oxygenation as 
estimated by the ratio of oxygen delivered (cardiac output x 
arterial oxygen content) to the oxygen consumed (arterial -
........... ..........
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m ixed venous oxygen content) was better in the plethoric blue 
bloater. Thus the emphysematous patients with their more 
pronounced gas exchange abnormalities are more starved of 
oxygen at the tissue level than the bronchitic, and it is possible 
that that the limited supply of this essential nutrient, oxygen, 
that leads to tissue loss and nutiitional depletion.
How does tissue hypoxia lead to weight loss? Results 
of the recent investigations on the role of inflammatory 
mediators, cytokines, paiticularly TNF- a  (cachexin) provide 
some clues. As noted, studies of TNF levels in COPD patients 
have revealed that not only ai*e serum levels of TNF - a  high 
in malnourished COPD patients but that monocytes from 
weight losing COPD patients produce a larger amount of 
cytokines both spontaneously and in response to stimulation
vitro results in an enhanced release of cytokines (Bain et al,
1994), and it is quite possible that such a phenomenon occurs 
in vivo in the ‘tissue hypoxic’ patients with em physem a, 
resulting in cachexia but not in the bronchitic patient with 
intact gas exchange. A similai" explanation might well hold in 
patients suffering from cachexia due to severe heait failure 
(Pittman and Cohen, 1964), who also have high levels of 
circulating TNF- a  (Levine et al, 19900.
. %
•II
(Di Francia et al, 1994; de Godoy et al, 1994). It has been 
demonstiated that priming of human monocytes by hypoxia in
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The hypotliesis that malnutrition in emphysema is 
simply a cytokine mediated mai'ker of chronic progressive 
tissue hypoxia will account for many of tlie features of 
emphysema associated weight loss that have hitherto been 
difficult to explain. Firstly, the significance of weight loss as a 
poor prognostic sign even in patients with relatively less 
airflow obstruction (W ilson et al, 1989). Weight loss, being 
the result of a gas exchange abnormality is simply a reflection 
of worsening tissue oxygenation, not worsening airflow 
obstruction. The onset of weight loss is merely a sign of 
advancing tissue hypoxia, of a degree approaching a state 
which in due course will be incompatible with cellulai* 
function. Also in keeping with this would be the finding of this 
study that there is no relation between routine tests of airflow 
obsti’uction (FEV 1) and REE and nutritional status. Second, 
the stepped decline in weight and nutritional status that is 
witnessed in emphysematous patients during states of stress, 
including infections, on a background of a gradual decline in 
body weight (Bates, 1973). This is likely the result of a surge 
of inflammatoiy activity associated with infections and other 
stresses (Tracey et al, 1989), occum ng in the context of a 
lesser but nevertheless significant hypoxia induced cytokine 
activity . The vai'iable values of energy expenditure noted in 
emphysema patients with the comparable degree of
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respiratory function abnom iality (Donahoe et al, 1989; Green 
and Muers, 1992; Ryan et al, 1993), may be accounted for by 
variations in the level of cytokine activity at the time of study, 
TNF levels rather than lung dysfunction now being the 
primary determinant of energy expenditure (Elborn et al, 
1993). Also, the absence of polycydiemia in emphysema, is 
explicable as the consequence of increased cytokine activity, 
TN F-a causing a relative suppression of the bone marrow 
(Tracey et al, 1988), counteracting the polycythem ic effect of 
tissue hypoxia. Lastly, the relative refractoriness of 
emphysema associated malnutrition to nutritional 
supplementation noted in previous studies(Otte et al, 1989; 
Rogers et al, 1994) and the studies that comprise this thesis is 
explained on the basis that however plentiful the supply of 
energy providing substiate is, the lack of availability of tissue 
oxygen as an essential element in the energy generating 
process (Lehninger, 1982) will result in failure of optimal 
utilisation of the proferred nutrients.
Neither the theory that tissue hypoxia is a feature of 
emphysematous and not bronchial type of obstructive lung 
disease, nor the view that the cachectic states of emphysema 
and chronic heart failure m ight be the result of the same 
mechanism are new (Filley et al, 1968). However the new 
findings from cell biology techniques has enabled the
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formulation of a theory that can offer a fuller explanation of 
the phenomenon of unexplained weight loss in these patients.
In summary (Figure 8.1), taking into account the results 
of the studies of this investigation and other more recent 
studies in the field, it appear's that weight loss in patients with 
clironic lung disease results mainly from severe tissue hypoxia 
which causes an increased susceptibility to and enhanced 
release of cytokines; the negative energy balance that 
accompanies every acute infective exacerbation makes a 
sizeable contribution to the nutritional depletion, but the 
increased work of breathing in itself is not a major reason for 
weight loss seen in these patients.
8.4 Directions for future research
Quite clearly tlie mechanistic theories which were 
tlie focus of much attention in the seventies and eighties have 
been superseded by theories which seek to explain phenomena 
at a molecular/ metabolic level. In this regai’d it is worth 
pointing out that whilst the cytokine profile of 
emphysematous, weight losing patients is being studied 
actively, there is a relative neglect of patients who do not lose 
weight and do not suffer from nutritional depletion (‘Blue 
bloaters’). It is ciaicial tliat these patients are studied as 
intensively as the weight losing patients as any mechanism 
which is postulated to account for weight loss in
ilk:
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emphysematous patients must be clearly demonstrated to be 
absent in those with COPD that do not.
Also worthy of note is that all studies of energy 
balance, including those that comprise this thesis have been 
cross-sectional. They have studied energy balance at 
particulai* points in time, at particulai* levels of lung 
dysfunction. However, if one were to seek an insight into the 
pathogenesis of energy imbalance and weight loss in patients 
with COPD, the most useful studies aie likely to be 
longitudinal ones which follow patterns of energy balance, 
lung function and nutritional status in a cohort of COPD 
patients over long periods of time. Whilst such studies may 
prove to be labour and cost intensive, they may settle once for 
all tlie issue of what the best predictors are of nutritional 
depletion. For example, the demonstration that progressive 
deterioration in diffusing capacity presages weight loss would 
imply that patients with worsening gas exchange are at risk of 
nutritional depletion, and thus worthy of specific attention as 
regards nutritional intervention. It would likewise be a matter 
of gr'eat interest to study the cytokine profiles of patients with 
COPD over a period of time, during periods of relative 
clinical stability and during episodes of stress (infections and 
otlier intercurrent illnesses) and correlate these with changes 
in nutritional status.
.
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One of the issues that is likely to dominate this area 
of research is the confounding of various measures of 
nutritional status, body composition and energy balance by 
oral steroid therapy, which is being used increasingly in 
patients with non-asthmatic cluonic obstructive airways 
disease (Mitchell et al, 1984). It is very likely that a number of
patients with COPD, who in tlie past may have lost weight 
and thus become visibly malnourished, will now maintain their 
weight due to lipogenesis associated with maintenance steroid 
therapy, but have a body composition that is akin to a state of 
profound malnutrition (severe reduction of fat free mass). It is
and accessible methods of measuring body composition be
*
I■
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imperative therefore that the potentially misleading use of
,body weight as an indicator of nutritional status be highlighted
i-
developed and used in patients with COPD.
As for attempts at improving prognosis by 
influencing the nutiitional status of malnourished COPD 
patients, it is clear that conventional nutritional 
supplementation programmes are not the answer. The 
identification of cytokines as mediators of tissue depletion 
raises the possibility of using anti- TNF agents to treat weight 
loss, but clearly any inteivention hoping to make significant 
impact on long tenn prognosis must deal with the underlying 
problem of tissue hypoxia, which is most likely the reason for 
these patients remaining relatively refractory to refeeding
I.
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regimes. In this regard the impact of lung ti ansplantation on 
the nutritional status and energy metabolism of malnourished 
patients undergoing the procedure for emphysema would be 
an area worthy of investigation.
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APPENDIX 1
A technical note on the indirect calorimetry
of note that the infrared sensor for CO2  is always sensitive to 
O2  concenti'ation due to physical effects.
(b) A ventilated canopy: This is a half ellipsoid made of 
transparent plastic 1 mm thick, which encloses the subject’s
a
system used in this study
The indhect calorimetry system used in this study was the 
Deltatrac Metabolic Monitor The following is a brief
account of its features, its merits and demerits.
A LI : General description
The Deltatrac Metabolic Monitor is an example of a 
flow through, open system of indirect calorimetiy. The
general configuration is as shown in Fig 2.2. The system
«measures oxygen consumption (V O2 ) and carbon dioxide (V 
CO2 ) production, and calculates tlie energy expenditure 
according to the modified Weir equation (Weir, 1941). The 
main components of the system aie:
(a) The gas analysers: Oxygen is measured by a differential 
oxygen sensor which uses the paramagnetic principle in a 
pneumatic bridge configuration. The carbon dioxide 
concentration is measured by an infrared sensor. It is worthy
If
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head. The volume of the canopy is about 25 liti'es. The canopy 
is provided with an inlet port which draws in room air and an 
outlet port which conducts room air diluted by expired gas to 
the gas analysers. The edge of the canopy extends to a plastic 
cloth which is used to make the canopy relatively air tight 
(Figure 2.3).
(c) Constant flow generator: This is constructed from a 
centrifugal fan which generates flows of around 40-50 liti'es 
per minute.
(d) M ixing chamber: The exph’ed air is drawn through (mixed 
with the air stream sucked in) a four liti'e mixing chamber 
from which a sample is drawn for analysis.
A 1.2 : Measurement principle
V CO2  and V O2  ai'e calculated from the difference 
in gas concenti'ations measured up and downsU'eam from the 
point where the subjects expired gas enters the airstream. If Q 
is the flow,
V CO2  = Q . A F CO2
V O2  = (Q/ (1-F IO 2 )) (A FO2 -FIO2  . A F CO2 ) 
where,
AF CO2  = FE CO2  - FI CO2  
AF O2  = FI O2  “ FE O2  ,
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FI O2  and FE O2  being the concenti'ation of oxygen in the 
inspired and expired gas, FI CO2  and FE CO2  the 
concentrations of carbon dioxide in the inspired and expired 
gases respectively.
The oxygen difference FI O2  - FE O2  is measured 
continuously with the differential oxygen sensor; the 
inspiratory cai'bon dioxide level is checked once every two 
minutes.
A 1.3 Advantages and disadvantages of the Deltatrac 
Metabolic Monitor
Clearly, the most important advantage of the
Deltatrac was its non-invasive nature. As demonstrated in
Chapter 2, the system, due to its non-invasive nature,
perm itted patients with lung disease to maintain a near normal
pattern of breathing whilst measurements of oxygen
consumption and caibon dioxide production were being made.
Also, cough, which is a relatively common symptom in this
patient population, was not inhibited by any apparatus.
Whilst indhect calorimeti'y with a ventilated hood 
system is cleaily a convenient technique with superior patient 
acceptability, the system is not without its faults. Firstly there 
is an error inherent in the system with regards to the 
measurement of oxygen and carbon dioxide tensions in the
Î.'F
i '
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expired gas. Although calibration both of the gas analysers 
and the flow constant ensures minimal eiTors, the Haldane 
hansformation which is used to calculate V 0% and RQ from 
expiratoiy volume only, amplifies errors progressively when 
the inspired fraction of oxygen is increased. The 
manufacturer’s estimate of the baseline error and gain errors 
are given in Table 1. From this data, the final relative error 
depending on the level of V CO2 , V O2 , FECO2 , FIO2  is 
computed as shown in Table 2. Inherent in the system is 
therefore a possible error of ±  3% in the measurement of V 
O2  and VCO2  values. Whilst this does not in any way negate 
the findings of the studies of the thesis (all studies had 
controls), this limitation needs to be borne in mind when the 
data are used in absolute tenns (for example to calculate 
energy needs during an infection).
In addition to the error inherent in the measurement, 
the other error that was not corrected for in the studies of 
REE that were conducted was correction for the incomplete 
oxidation of proteins in the body. In order to achieve a greater 
degree of accuracy measurements of urinary nitrogen 
excretion are made and an appropriate correction made of the 
REE values. But the eiTors induced if urinaiy nitrogen is not 
measured are small, and given that in all studies there were a 
group of controls, it seems reasonable to assume that this 
error did not in any way affect the results of the studies.
1;
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Also the fact that measurements made over a short 
period of time are being extr apolated to give 24 hour energy 
expenditure merits emphasis. In this regai'd, it might have 
been ideal and relatively simpler to study patients with COPD 
and matched controls by dir ect calorimetry in a calorimeter 
chamber over 24 hours, pursuing their own ‘normal’ daily 
activities, to settle the issue of whether 24 hour energy 
expenditure is indeed elevated in stable COPD patients. Such 
a system was unavailable in the institution where the 
investigations comprising this thesis were conducted.
I
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Errors Carbon-dioxide Oxygen
Baseline ±  0.005 ±0.01
Gain ± 0 .5 ± 0 .5
Table A 1.1 : Baseline and Gain errors assumed whilst
computing systematic errors in Deltatrac measurements 
(Manufacturer’s data from Deltatrac prototypes, Datex 
Insti'umentaiium Corp., 1993)
-I'!
V CO2  (ml/ mill)
100 200 300
V C O 2 ± 3.5 % ± 2.5 % ± 2.2 %
V O 2 ±  5.5 % ± 3.5 % ± 3.0 %
RQ ± 7 .5 % ± 4.5 % ± 3.5 %
Table A 1 .2: Maximum possible relative errors in 
measurement of V O2 , VCO2  and RQ at an RQ level of 0.85.
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APPENDIX 2
This section presents data supporting the use of a time period 
of 20 minutes for making energy expenditure measurements 
and the data on the variability of V O2  and V CO2  
measurements.
A 2.1 Duration of indirect calorimetry
In all the studies indirect calorimetry was performed 
for a period of twenty minutes. The data obtained in the first 
five minutes was discarded and the data obtained over the 
next fifteen minutes was used to calculate REE.
The data obtained in the first five minutes was discarded as 
the oxygen consumption and cai'bon dioxide production 
values were very vai'iable as the subjects were settling into a 
regular breathing pattern, commencing from a state of relative 
hyperventilation (Figure A 2.1). On the basis of data collected 
in 5 patients with COPD who underwent calorimetry for one 
hour it was found that variability was consistently least i.e., V 
O2  and V CO2  values were more stable between ten and 
tliirty minutes of measurement, paiticularly between ten and 
twenty minutes of measurement. There were wide individual 
variations in the stability of these measurements over time but 
most patients tended to show a greater variation in these 
measures after about 30 minutes in the hood (Table A2.1).
I
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These variations were associated with visible signs of 
restlessness (crossing of legs, sighing breathing, movement of 
arms across chest) and it therefore seemed appropriate to 
restrict the duration of measurement to the shortest acceptable 
duration with least valuations. The measurement period 
between five and twenty minutes was therefore chosen.
I
t :
:
A 2.2 Coefficients of variation for V 0% and V CO2  
measures with the Deltatrac Metabolic Monitor
V O2  and V CO2  were measured in 3 patients and 2
conti’ols on 3 different occasions, each eight weeks apait. The
measurements were made for a period of 20 minutes on each
occasion, the data obtained in the first five minutes being .discai'ded. The mean V O2  and V CO2  measured over the last 
15 minutes on tlie three occasions in the five subjects (three 
patients, two controls) ai*e shown in Table A2.2. The 
coefficient of variation for V 02and V CO2  ranged from 3-
8%. ■s
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DELTATRAC M e t a b o l i c  M o n i t o r  P r o g .  r e v .  8 7 6 8 4 9 - 1  
PATIENT:  m a l e  163 cm 48 kg 72 y r  1 . 5 3  m2
CANOPY MODE ADULT 1 6 - J u n - 1 992
CALIBRATIONS:
1 6 - J u n - 1 9 9 2  0 3 : 4 5
RESULTS IN STPD
AMB. C02 
0 . 0 4  %
002 MEAS. /SET 
5 . 0 7  /  5 . 0 0  %
02 MEAS. /SET 
9 7 . 0  /  9 5 . 0  !
NO AVERAGING 
TIME VC02 V02 RQ EE F i 0 2 FC02* F i 0 2 - F
h : min m l / m i n m l / m i n k c a l / d % % %
09 49* 185 212 0 . 8 8 1460 2 0 . 9 0 . 4 8 0 . 5 3
03 50* 177 204 0 . 8 7 1410 2 0 . 9 0 . 4 6 0 . 51
03 51 * 178 1 90 0 . 9 4 1330 2 0 . 9 0 . 4 6 0 . 4 8
09 52* 138 152 0 . 9 1 1050 2 0 . 9 0 . 3 6 0 . 3 8
09 53* 129 156 0 . 8 3 1060 2 0 . 9 0 . 3 3 0 . 3 9
09 54 163 184 0 . 8 9 1270 2 0 . 9 0 . 4 2 0 . 4 6
09 55 146 176 0 . 8 3 1200 2 0 . 9 0 . 3 8 0 . 4 4
09 56 149 176 0 . 8 5 1200 2 0 . 9 0 . 3 9 0 . 4 4
09 57 167 189 0 . 8 9 1300 2 0 . 9 0 . 4 3 0 . 4 7
09 58 158 184 0 . 8 6 1260 2 0 . 9 0 . 4 1 0 . 4 6
09 59 158 175 0 . 9 0 1220 2 0 . 9 0 . 4 1 0 . 4 4
10 00 148 172 0 . 8 6 1 180 2 0 . 9 0 , 3 8 0 . 4 3
10 01 135 159 0 . 8 5 1080 2 0 . 9 0 . 3 5 0 . 4 0
10 02 137 164 0 . 8 3 1110 2 0 . 9 0 . 3 5 0 . 41
10 03 135 166 0 . 8 1 1 130 2 0 . 9 0 . 3 5 0 . 4 1
10 04 153 188 0 . 8 2 1280 2 0 . 9 0 . 4 0 0 . 4 7
10 05 152 176 0 . 8 6 1210 2 0 . 9 0 . 3 9 0 .  44
10 06 142 170 0 . 8 4 1 160 2 0 . 9 0 . 3 7 0 . 4 2
10 07 1 37 1 64 0 . 8 3 1 120 2 0 . 9 0 . 3 6 0 , 4 !
F ig u re  A 2 .1 : REE measurements showing a progressive 
drop in oxygen consumption and cai'bon dioxide production 
values in the first five minutes.
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Time interval V O 2  (ml /  min) V CO2  (ml/min)
0 - 5  min 318 241
6 -1 0  min 272 213
1 1 -1 5  min 283 222
16 - 20 min 277 222
21 “ 25 min 284 210
26 - 30 min 289 228
3 1 -3 5  min 294 232
36 - 40 min 278 219
41 - 45 min 270 208
46 - 50 min 285 216
5 1 -5 5  min 279 222
56 - 60 min 291 235
Table A2.1 : Indirect calorimeti’y data from a patient with 
lung disease showing oxygen consumption and carbon dioxide 
production measurements over an hour. Note greater 
vaiiability in the measures in the period after thir ty minutes 
compared with the periods between five and twenty minutes.
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